Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027544	ex-tbvrvi	— (—)	3619	13898	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

COPD, hospital admission 2, with asthma infections

639

1013

5.58

308.04

4.1

3.5

—

ILD medications: prednisolone, methylprednisolone, prednisone

1359

1675

4.65

307.65

4.1

3.6

—

ILD medications

1321

1687

4.36

307.65

4.0

3.7

—

Oral corticosteroids

1415

1873

4.65

307.65

4.1

3.6

—

All pneumoniae

1692

1511

7.92

307.65

4.1

3.7

—

Asthma, hospital admissions , main diagnosis only

1125

2287

4.48

307.65

4.3

3.6

—

Asthma, hospital admission 2, infections

1043

1583

6.66

307.65

4.5

3.5

—

Haemorrhage from respiratory passages

619

848

6.98

307.65

4.1

3.4

—

COPD (mode)

555

201

22.70

307.65

3.9

2.9

—

Non-allergic asthma (mode)

358

136

27.01

307.65

4.7

3.0

—

Other pulmonary diagnosis

785

335

11.89

307.65

3.8

2.9

—

Abnormal findings on diagnostic imaging of lung

1085

1545

7.13

307.65

4.3

3.3

—

Cough

631

934

6.64

307.65

4.3

3.7

—

Bacterial pneumoniae

812

781

9.53

307.65

4.5

3.3

—

Influenza and pneumonia

1674

1484

7.58

307.65

4.1

3.7

—

Asthma and opportunity respiratory infection

334

117

35.55

307.65

6.9

3.0

—

Non-allergic asthma (mode), excluding more controls

358

126

29.15

307.65

4.7

3.1

—

Asthma, unspecified (mode)

757

309

19.87

307.65

4.0

2.8

—

Bacterial pneumonia, not elsewhere classified

790

737

9.83

307.65

4.5

3.3

—

Asthma, excluding more controls

1121

296

20.62

307.65

4.3

3.0

—

Asthma (diagnoses ohter than nonallergic)

1244

2250

4.82

307.65

4.2

3.6

—

ILD differential diagnosis

782

337

11.77

307.65

3.8

2.9

—

Inflammatory bowel disease treatment related agents

1383

1896

4.20

307.65

4.1

3.6

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1191

1898

6.00

307.65

4.3

3.4

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1589

1102

9.27

307.65

4.3

3.5

—

Pneumonias (Asthma/COPD co-morbidities)

1723

1481

8.26

307.65

4.2

3.5

—

Asthma/COPD (KELA code 203)

1268

1642

5.54

307.65

4.4

3.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1680

1535

7.88

307.65

4.1

3.6

—

Other chronic obstructive pulmonary disease

755

998

6.49

307.65

4.0

3.1

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

387

181

16.86

307.65

3.5

3.8

—

COPD/asthma/ILD related infections

1142

1102

5.26

307.65

4.1

3.5

—

Asthma

1165

334

19.11

307.65

4.3

2.9

—

COPD

806

1019

6.74

307.65

4.0

3.1

—

Chronic lower respiratory diseases

1619

1649

5.40

307.65

4.3

3.4

—

First line medication for Crohn's disease

1196

1660

3.98

307.65

4.0

3.7

—

Asthma-related pneumonia

865

1019

8.86

307.65

4.7

3.2

—

Early onset COPD, excluding more controls

392

157

25.95

307.65

4.3

2.9

—

Later onset COPD, excluding more controls

344

124

22.43

307.65

3.8

2.7

—

COPD/asthma related infections

1142

1102

5.26

307.65

4.1

3.5

—

Asthma-related pneumonia or sepsis

866

1021

8.86

307.65

4.7

3.3

—

Asthma-related infections

1043

1583

6.66

307.65

4.5

3.5

—

Asthma (mode)

994

337

16.50

307.65

4.0

2.9

—

Asthma, hospital admissions 3, pneumonia

866

1021

8.86

307.65

4.7

3.3

—

Lung cancer and mesothelioma

358

125

25.48

307.65

3.1

—

COPD differential diagnosis

782

337

11.77

307.65

3.8

2.9

—

701

1064

6.70

307.65

4.6

3.5

—

1589

1102

9.27

307.65

4.3

3.5

—

ILD, hospital admission 2, with pulmonary infections

326

179

19.85

307.65

3.5

3.2

—

Excluding asthma or asthma-COPD overlap

790

335

11.96

307.65

3.9

2.9

—

Bacterial pneumonia (organism specified)

870

1187

6.90

307.65

4.4

3.2

—

Asthma (only as main-diagnosis), excluding more controls

1042

296

21.43

307.65

4.4

3.0

—

Asthma, including avohilmo

1407

2127

3.90

307.65

4.1

3.6

—

Asthma, unspecified (mode), excluding more controls

740

276

21.55

307.65

4.0

2.9

—

Pneumonia, organism unspecified

1623

1419

8.50

307.65

4.1

3.6

—

Asthma (only as main-diagnosis)

1082

334

19.98

307.65

4.3

2.9

—

Bronchiectasis

478

158

35.76

307.65

6.0

3.2

—

ILD, hospital admissions 3, with pneumonia sepsis

291

156

20.46

307.65

3.5

3.1

—

ILD, hospital admissions

413

527

8.36

305.11

3.5

3.6

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

585

858

6.04

304.58

4.2

3.5

—

Other interstitial pulmonary diseases

415

537

8.23

302.91

3.5

3.6

—

Interstitial lung disease endpoints

415

540

8.19

301.48

3.5

3.6

—

Interstitial lung disease

415

540

8.19

301.48

3.5

3.6

—

Other respiratory diseases principally affecting the interstitium

448

638

7.42

300.01

3.5

3.6

—

Other chronic obstructive pulmonary disease, including avohilmo

841

1679

4.27

296.90

4.0

3.5

—

Other diseases of pleura

749

1499

4.55

291.87

3.9

3.4

—

COPD, hospital admissions

758

1474

4.48

284.79

4.0

3.5

—

Respiratory insufficiency

180

35.07

283.93

4.1

2.8

—

COPD, early/later onset

759

1479

4.45

283.28

4.0

3.5

—

Dyspnoea

1057

2323

3.54

282.76

3.8

3.7

—

ILD, hospital admissions 1, main diag only

379

483

8.40

280.52

3.4

3.5

—

Abnormalities of breathing

913

1315

4.17

279.67

3.8

—

Undetermined asthma, excluding more controls

186

27.77

273.93

4.6

3.5

—

Other acute lower respiratory infections

743

1707

4.24

272.36

4.6

3.6

—

Diseases of the respiratory system

549

364

7.63

272.22

4.0

3.6

—

Other bacterial diseases

1083

2210

3.43

268.78

4.4

3.5

—

Undetermined asthma

186

24.56

262.02

4.6

3.3

—

Allergic asthma (mode), excluding more controls

215

125

17.13

257.26

4.1

3.2

—

Acute bronchitis

613

1318

4.66

255.39

4.4

3.5

—

Allergic asthma (mode)

215

134

15.98

248.45

4.1

3.2

—

Bacterial infection, other or unspecified

708

1614

4.04

239.22

3.4

—

1127

1853

3.24

234.44

4.2

3.5

—

COPD, hospital admissions 1, only main diagnosis

598

1148

4.57

230.88

4.0

3.4

—

Infections, IBD-co-morbidities

305

237

9.66

218.86

6.8

3.9

—

COPD related to multimorbidity

614

1268

4.19

211.96

4.0

3.5

—

Early onset COPD

392

704

5.76

207.90

4.3

3.5

—

Bacterial Sepsis

634

1462

3.94

206.30

3.7

3.6

—

Bronchitis

1057

2450

2.86

192.11

4.3

3.6

—

ILD medications: immunosuppressive drugs

568

1411

3.91

188.42

4.0

3.6

—

136

24.42

184.05

6.4

3.7

—

Implicit bacterial Sepsis

556

1322

3.94

182.58

3.7

3.5

—

Obesity related asthma

399

822

4.96

180.70

4.2

3.3

—

Symptoms and signs involving the circulatory and respiratory systems

851

1316

3.27

176.00

4.0

3.8

—

All influenza

290

470

6.30

170.43

4.3

3.5

—

Infection due to other mycobacteria

114

31.54

167.94

12.9

3.5

—

Viral pneumonia

199

216

9.52

166.33

3.8

3.5

—

Chronic sinusitis

494

1288

3.90

164.57

5.3

3.6

—

COPD-related respiratory insufficiency

265

411

6.78

163.92

4.2

3.5

—

Fever of other and unknown origin

593

1617

3.45

161.75

3.8

3.9

—

Emphysema

172

160

11.39

161.29

4.4

3.1

—

Tramadol

777

1650

3.06

157.90

3.6

3.8

—

Implicit Sepsis

780

2084

2.95

156.80

3.7

—

Lung transplantation

61.50

155.91

5.4

3.2

—

Other diseases of the respiratory system

355

758

4.84

154.75

4.0

3.5

—

Other respiratory disorders and diseases

355

758

4.84

154.75

4.0

3.5

—

Lung transplant status

60.58

153.73

5.5

3.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

934

2549

2.65

151.71

3.8

—

Pain in throat and chest

680

1289

3.25

150.17

4.0

3.7

—

Asthma and allergy, excluding more controls

117

19.24

148.37

4.1

3.6

—

Atypical mycobacterium lung infection

41.27

148.25

13.4

2.9

—

Bleeding

852

2325

2.70

143.23

3.8

3.7

—

Asthma and allergy

117

17.26

141.00

4.1

3.5

—

Continuous positive airway pressure

289

463

5.52

139.87

3.5

3.8

—

Chronic rhinitis, nasopharyngitis and pharyngitis

364

857

4.32

139.66

4.0

3.6

—

Suppurative and necrotic conditions of lower respiratory tract

166

185

9.69

137.24

4.0

3.8

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

380

770

4.25

133.93

3.3

3.7

—

Respiratory tuberculosis, confirmed

103

21.26

132.19

13.0

3.7

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

348

662

4.51

131.78

3.2

3.8

—

Codes for special purposes

465

1353

3.49

131.77

4.0

3.7

—

Provisional assignment of new diseases of uncertain etiology

464

1352

3.48

131.20

4.0

3.7

—

Idiopathic pulmonary fibrosis

195

282

7.36

129.29

3.8

3.5

—

Certain infectious and parasitic diseases

812

1487

2.75

127.34

4.3

3.3

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

103

19.38

126.86

13.0

3.7

—

Persons encountering health services for specific procedures and health care

927

2381

2.43

121.66

4.1

3.7

—

Covid-19 confirmed case

340

868

3.99

117.13

3.8

3.6

—

Tuberculosis, IBD comorbidity

183

275

7.01

116.85

9.1

3.5

—

Tuberculosis

173

247

7.41

115.94

9.4

3.6

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

261

511

4.97

115.45

3.0

3.8

—

Tuberculosis, wide

184

292

6.63

111.48

9.1

3.6

—

Heart failure, not strict

725

1969

2.57

109.31

3.6

3.7

—

Pleural effusion

246

519

4.89

108.96

3.5

3.6

—

Condition for Implicit Sepsis (Organ dysfunction codes)

760

2269

2.46

106.26

3.8

—

Respiratory tuberculosis, confirmed and not-confirmed

155

217

7.58

105.83

9.9

3.7

—

Respiratory tuberculosis

155

217

7.58

105.83

9.9

3.7

—

Malaise and fatigue

485

1373

2.98

101.68

3.6

3.7

—

Abscess of lung

20.75

101.15

4.2

4.3

—

Non-small cell lung cancer

261

624

4.31

98.84

3.0

3.5

—

Later onset COPD

378

881

3.44

97.82

3.7

3.4

—

Pneumonia due to other infectious organisms, not elsewhere classified

16.54

95.66

3.7

3.5

—

Viral Sepsis

245

575

4.36

94.79

4.2

3.6

—

Septicaemia

415

1319

3.07

94.72

3.5

3.3

—

Implicit viral Sepsis

244

574

4.35

94.11

4.1

3.6

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

244

223

5.52

93.94

4.2

3.3

—

Oxycodone

378

1163

3.19

92.29

3.6

3.7

—

Certain disorders involving the immune mechanism

245

590

4.25

91.67

4.2

3.7

—

ILD-related respiratory insufficiency

106

112

10.38

91.54

3.5

4.4

—

Care involving use of rehabilitation procedures

570

2150

2.54

91.19

4.3

3.6

—

Heart failure,strict

544

1482

2.68

90.58

3.5

3.6

—

Transplanted organ and tissue status

168

299

5.83

90.33

4.5

3.8

—

Codeine

739

1721

2.38

89.61

3.7

4.0

—

Speech therapy

316

929

3.47

88.61

4.0

3.6

—

Examination and observation for other reasons

534

1204

2.72

87.36

3.9

3.7

—

Diseases of oesophagus, stomach and duodenum

867

2454

2.16

86.90

3.8

3.7

—

L04AA Selective immunosuppressants

247

624

4.04

86.55

4.1

3.7

—

Unspecified acute lower respiratory infection

199

430

4.74

85.54

4.6

3.4

—

Explicit Sepsis

424

1440

2.86

85.44

3.5

3.6

—

Renal tubulo-interstitial diseases

726

2507

2.24

83.72

3.7

3.8

—

Suggestive for eosinophilic asthma

142

231

6.35

83.69

4.4

3.5

—

General symptoms and signs

823

1895

2.19

80.84

3.8

4.0

—

Acute sinusitis

423

1431

2.78

80.81

4.7

3.6

—

L04AD Calcineurin inhibitors

161

309

5.38

79.69

4.4

3.9

—

Malignant neoplasm of respiratory system and intrathoracic organs

298

822

3.41

79.53

3.0

3.5

—

Heart failure, strict

583

1756

2.42

78.66

3.5

3.6

—

Malignant neoplasm of bronchus and lung

267

726

3.52

75.15

2.8

3.5

—

Other diseases of upper respiratory tract

885

2260

2.05

75.06

4.2

3.7

—

Other septicaemia

351

1188

2.94

74.78

3.5

3.3

—

Pain in limb

628

2014

2.27

74.19

3.6

3.9

—

All influenza (not pneumonia)

141

256

5.60

73.86

3.9

3.7

—

Immunodeficiencies

125

8.32

73.78

4.9

3.7

—

Pneumocystosis

14.29

72.27

3.5

3.6

—

Dental caries

251

717

3.52

72.27

4.5

3.8

—

All-cause Heart Failure

562

1739

2.36

71.70

3.5

3.6

—

Immunodeficiency with predominantly antibody defects

11.38

70.67

4.1

3.9

—

Exposure to unspecified factor

748

2832

2.06

70.62

3.8

—

Opioids

711

1740

2.16

68.52

3.6

4.0

—

Aspergillosis

22.46

68.19

6.7

4.2

—

Pulmonary heart disease, diseases of pulmonary circulation

335

1201

2.83

66.88

3.7

3.5

—

Protozoal diseases

10.13

65.93

3.5

3.9

—

Dentinal caries

223

636

3.54

64.98

4.6

3.7

—

Persons encountering health services in other circumstances, wide

924

2519

1.91

64.51

4.1

3.7

—

Benign neoplasm of colon, rectum, anus and anal canal

470

1395

2.43

64.32

3.8

3.7

—

Other pleural conditions

152

335

4.67

64.04

3.4

3.5

—

Codeine or tramadol medication

871

2506

1.94

63.94

3.7

3.8

—

Diagnoses used for exclusion with ILD

280

935

3.04

63.70

3.7

3.5

—

Fungal Sepsis

107

8.41

63.65

4.4

4.2

—

Voice disturbances

265

865

3.11

62.71

3.7

—

Anaemias

162

224

4.85

62.56

4.1

4.4

—

Viral pneumonia (unknown virus, not influenza)

151

6.77

62.18

3.1

3.8

—

Acute upper respiratory infections of multiple and unspecified sites

546

1858

2.22

61.53

4.4

3.7

—

Simple and mucopurulent chronic bronchitis

8.50

61.03

4.6

3.5

—

Implicit fungal Sepsis

102

8.44

60.69

4.5

4.3

—

Pyothorax

137

7.17

60.69

3.8

4.0

—

Heart failure and antihypertensive medication

264

543

3.26

60.14

3.4

3.9

—

Erysipelas

448

1768

2.33

59.25

3.7

3.4

—

Acute upper respiratory infections

783

2551

1.93

59.11

4.3

3.7

—

Metabolic disorders

723

2279

1.98

58.49

4.0

3.8

—

Other heart diseases

338

819

2.75

58.06

3.3

4.2

—

Dysphagia

249

823

3.07

57.71

4.5

3.6

—

Any reimbursement code in KELA

332

584

2.86

56.32

4.5

4.6

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

820

2497

1.88

55.95

4.1

3.8

—

Other soft tissue disorders, not elsewhere classified

665

2059

2.01

55.61

3.7

3.9

—

Viral hepatitis, IBD co-morbidity

10.06

55.24

3.6

4.3

—

Benign neoplasm: Colon

412

1340

2.38

54.87

3.9

3.7

—

Pain, not elsewhere classified

230

748

3.11

54.74

3.7

—

Medical observation and evaluation for suspected diseases and conditions

529

1225

2.23

54.65

3.8

3.7

—

Other and unspecified immunodeficiencies with predominantly antibody defects

16.85

54.47

4.6

4.0

—

Renal failure

416

1658

2.32

54.21

3.5

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

109

211

5.37

53.73

2.8

3.8

—

Any gastric operation

535

1227

2.20

53.49

4.2

3.7

—

GASTRO-related operations

535

1227

2.20

53.49

4.2

3.7

—

Aplastic and other anaemias

413

1729

2.29

52.64

3.4

3.6

—

L04AX Other immunosuppressants

424

1907

2.24

52.09

3.7

3.8

—

Second line medication for Crohn's disease

430

1948

2.22

51.89

3.7

3.9

—

Polyarthropathies

535

1706

2.10

51.68

3.7

3.8

—

Gastro-oesophageal reflux disease

520

2236

2.07

51.38

3.7

—

ILD medications: pirfenidone

16.89

50.34

3.5

—

Heart failure and bmi 25plus

297

766

2.70

50.02

3.2

3.5

—

Symptoms and signs involving speech and voice

292

1135

2.60

49.88

3.6

3.7

—

Diverticular disease of intestine

581

1941

2.00

49.14

3.6

3.7

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

382

1660

2.27

48.32

3.6

3.7

—

Systemic connective tissue disorders

304

1231

2.50

47.67

3.6

3.7

—

Constipation

661

2534

1.88

47.34

3.9

3.7

—

Diaphragmatic hernia

330

1393

2.40

47.26

3.7

3.6

—

Other heart diseases, wide

606

1934

1.95

47.24

3.4

4.0

—

Chronic periodontitis

159

454

3.57

46.94

4.6

3.7

—

Other diseases of intestines

725

2297

1.84

46.80

3.7

3.9

—

Pulmonary embolism

275

1074

2.59

46.57

3.7

3.5

—

Other anaemias

379

1649

2.24

46.17

3.4

3.6

—

Other and unspecified anaemias

374

1633

2.24

45.49

3.4

3.6

—

Unspecified privation

131

335

4.00

45.47

4.4

3.8

—

Non-small cell lung cancer, adenocarcinoma

109

246

4.60

44.87

2.8

3.7

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

109

246

4.60

44.87

2.8

3.7

—

Pulmonary heart disease

275

1098

2.54

44.50

3.7

3.5

—

Invasive ventilation

101

216

4.81

44.28

3.3

3.7

—

Autoimmune diseases related-to ILD

568

2639

1.90

44.08

3.7

3.9

—

Chronic gastritis

268

1064

2.55

43.92

3.6

3.5

—

Autoimmune diseases excluding thyroid diseases

758

2369

1.78

43.62

3.9

—

Mycoses

233

869

2.72

43.34

4.7

3.6

—

Osteoporosis

243

880

2.67

43.22

3.8

3.5

—

Fall on same level

797

2553

1.75

43.21

3.5

4.0

—

Osteopathies and chondropathies

423

1953

2.07

42.18

3.8

3.7

—

Disorders of lipoprotein metabolism and other lipidaemias

626

2133

1.86

42.04

3.4

3.8

—

Benign neoplasm of colon, rectum, anus and anal canal

505

2360

1.95

41.97

3.8

3.6

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

211

509

2.93

41.40

3.8

4.0

—

Intestinal infectious diseases

652

2837

1.80

41.35

3.7

3.9

—

Non-ischemic cardiomyopathy

273

909

2.49

41.02

3.6

3.7

—

Venous thromboembolism

444

2166

2.01

40.77

3.8

3.7

—

Autoimmune diseases excluding thyroid diseases, strict definition

727

2307

1.76

40.38

3.8

3.9

—

Parasetamol

527

1372

1.97

40.15

3.6

4.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

488

2311

1.93

39.76

3.6

3.8

—

Acute renal failure

207

766

2.74

39.24

3.5

3.6

—

Complications of surgical and medical care, not elsewhere classified

686

2824

1.75

39.21

3.7

3.8

—

Use of hypnotics and sedatives

748

2520

1.72

38.77

3.7

—

Pain in joint

399

1268

2.09

38.33

4.1

4.2

—

Ulcer of lower limb, not elsewhere classified

159

520

3.12

37.85

3.5

3.7

—

Substance abuse, excluding more controls

413

1808

2.01

37.70

3.9

—

Diseases of arteries, arterioles and capillaries

536

2166

1.86

37.56

3.5

3.6

—

Primary_lymphoid and hematopoietic malignant neoplasms

211

806

2.65

37.49

3.6

3.7

—

Abdominal and pelvic pain

705

2031

1.75

37.43

3.5

4.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

343

1593

2.13

37.30

4.1

—

ILD medications: azathioprine

110

289

3.85

36.70

4.3

3.3

—

Childhood asthma (age<16), excluding more controls

9.57

36.41

5.5

4.2

—

119

333

3.63

36.28

4.6

3.6

—

Cardiovascular diseases (excluding rheumatic etc)

350

933

2.18

35.83

4.3

—

Diseases of pulp and periapical tissues

255

1087

2.37

35.81

3.8

3.7

—

Explicit bacterial Sepsis

113

309

3.73

35.71

3.3

3.7

—

Allergic conjunctivitis

352

1688

2.06

35.32

4.1

—

Childhood asthma (age<16)

9.11

35.24

5.5

4.1

—

Pneumothorax

203

4.44

35.17

4.9

3.7

—

Dialysis, with operation codes

138

435

3.23

34.99

4.0

3.5

—

Oedema, not elsewhere classified

235

972

2.43

34.89

3.5

3.7

—

Adjustment and management of implanted device

183

677

2.74

34.78

3.4

3.5

—

Conjunctivitis

458

2141

1.87

34.02

4.0

—

Sarcoidosis

133

417

3.24

34.00

3.7

3.8

—

Symptoms and signs involving the digestive system and abdomen

691

2031

1.71

33.87

3.7

4.0

—

Other necrotizing vasculopathies

236

4.09

33.66

4.6

4.0

—

Substance use, excluding alcohol

155

534

2.93

33.59

4.1

3.9

—

Enlarged lymph nodes

134

425

3.19

33.54

3.7

3.9

—

Persons encountering health services for specific procedures, not carried out

198

4.38

33.52

3.9

3.8

—

Streptococcal septicaemia

251

3.95

33.25

3.4

3.1

—

Disorders of conjunctiva

514

2406

1.80

33.19

4.0

3.9

—

Diseases of the skin and subcutaneous tissue

674

1981

1.71

33.15

4.0

3.8

—

Other necrotizing vasculopathies (FG)

188

4.49

33.09

4.5

4.2

—

Nephropathy related operations

132

420

3.20

32.99

3.6

3.7

—

Benzodiazepine use

676

2886

1.67

32.98

3.9

3.7

—

Special screening examination for infectious and parasitic diseases

154

384

3.02

32.73

4.2

3.7

—

Other medical care

311

1456

2.10

32.67

3.6

3.5

—

Spondylopathies

578

2005

1.76

32.62

3.6

3.7

—

Bacterial intestinal infections, IBD co-morbidities

165

599

2.79

32.52

3.7

3.5

—

Chronic kidney disease

258

1149

2.26

32.46

3.6

3.5

—

Other symptoms and signs involving the circulatory and respiratory systems

117

5.49

32.43

3.2

3.5

—

Viral pneumonia (known virus, not influenza)

8.35

32.24

4.8

3.1

—

Mental and behavioural disorders due to psychoactive substance use

423

2136

1.88

32.17

3.9

3.8

—

Acute tubulo-interstitial nephritis

430

2045

1.88

32.16

3.7

—

Substance abuse

413

2099

1.89

32.10

3.9

3.8

—

Pure hypercholesterolaemia

536

2032

1.78

32.09

3.4

3.8

—

Benign neoplasm: Colon

421

2212

1.88

32.05

3.9

3.6

—

ILD medications: nintedanib

17.05

32.02

3.5

3.3

—

Azathioprine

110

318

3.50

31.94

4.3

3.4

—

Other bacterial intestinal infections

163

594

2.78

31.90

3.7

—

Secondary right heart disease

142

5.04

31.85

3.5

—

Nasal polyp

166

614

2.74

31.56

5.3

3.6

—

Gingivitis and periodontal diseases

623

1875

1.72

31.52

3.9

3.7

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

630

2551

1.69

31.29

3.6

3.8

—

Vocal cord dysfunction

110

296

3.49

31.23

3.3

3.8

—

Other pulmonary heart/vessel disease

157

4.75

31.01

3.5

3.6

—

Syncope and collapse

315

1365

2.06

30.82

3.5

3.7

—

Sleep disorders (combined)

666

2646

1.66

30.79

3.8

—

Hypertensive diseases (excluding secondary)

305

825

2.16

30.79

3.6

4.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

211

889

2.40

30.62

3.6

—

Atrial fibrillation and flutter

226

614

2.42

30.45

3.4

4.1

—

Paroxysmal tachycardia

162

500

2.76

30.35

3.5

4.2

—

Vasomotor and allergic rhinitis

217

916

2.35

30.10

4.3

3.9

—

DVT of lower extremities and pulmonary embolism

333

1689

1.98

29.86

3.7

3.6

—

Other disorders of skin and subcutaneous tissue

487

2548

1.76

29.82

3.6

3.7

—

Reimbursement for rheumatic diseases

398

2145

1.86

29.73

4.0

3.8

—

Unspecified chronic bronchitis

6.45

29.62

4.8

3.9

—

Allergic bronchopulmonary aspergillosis (ABPA)

83.90

29.50

7.6

2.8

—

Atrial fibrillation and flutter with reimbursement

204

526

2.51

29.43

3.4

4.1

—

Cerebrovascular diseases (FINNGEN)

211

629

2.42

29.07

3.5

4.1

—

Infections of the skin and subcutaneous tissue

376

2006

1.88

28.81

4.2

3.8

—

Covid-19 suspected case

146

531

2.78

28.68

4.0

3.9

—

Bronchitis, not specified as acute or chronic

175

4.29

28.61

4.0

3.7

—

Other systemic involvement of connective tissue (FG)

200

844

2.38

28.43

3.3

3.8

—

Chronic viral hepatitis

117

5.16

28.32

3.7

4.2

—

Other viral hepatitis

141

4.70

28.06

3.6

4.0

—

Diseases of oral cavity, salivary glands and jaws

615

1896

1.67

27.90

3.7

—

Cardiovascular diseases

299

778

2.10

27.83

4.5

4.6

—

Other diseases of blood and blood-forming organs, wide

178

726

2.48

27.78

3.5

3.6

—

Cardiomyopathy

148

552

2.71

27.75

3.5

3.7

—

Neoplasms

436

1277

1.84

27.67

4.2

4.1

—

Parodontitis or operation codes

604

2721

1.64

27.66

4.0

3.7

—

Parodontitis

603

2719

1.64

27.61

4.0

3.7

—

Chronic periodontitis, including avohilmo

600

2721

1.64

27.29

4.0

3.7

—

Pneumonia due to Streptococcus pneumoniae

6.76

27.28

3.7

3.3

—

Disorders of eyelid, lacrimal system and orbit

568

2704

1.66

27.13

3.8

—

Abnormal findings on examination of blood, without diagnosis

357

1792

1.88

27.08

4.1

3.5

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

636

2774

1.61

26.93

3.7

3.8

—

Injuries to the thorax

331

1748

1.91

26.64

3.5

3.7

—

Other antidepressants

695

2282

1.59

26.43

3.7

3.9

—

Complications of procedures, not elsewhere classified

527

2742

1.67

26.40

3.8

3.7

—

Benign neoplasms

440

1394

1.79

26.21

4.4

4.0

—

Endocrine, nutritional and metabolic diseases

496

1455

1.74

26.10

3.8

4.3

—

Open wound of lower leg

126

447

2.86

26.05

4.1

3.8

—

Complications of medical and surgical care

488

2756

1.69

26.00

3.7

—

Spondylosis

385

1834

1.81

25.74

3.6

3.7

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

8.31

25.72

3.3

3.8

—

Benign neoplasm: Colon, unspecified

191

829

2.32

25.66

3.8

3.7

—

Persons encountering health services for examination and investigation

438

1225

1.80

25.66

3.8

3.7

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

551

1963

1.67

25.61

3.5

3.8

—

Malignant neoplasm, wide definition for exclusion

551

1964

1.66

25.56

3.5

3.8

—

Other specific joint derangements/joint disorders

448

1724

1.75

25.53

3.9

—

Headache

357

1620

1.85

25.51

3.8

4.0

—

Sleep apnoea

609

2575

1.61

25.50

3.8

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

550

1963

1.66

25.40

3.5

3.8

—

Low back pain

464

2091

1.72

25.37

3.6

3.9

—

Dorsalgia

638

2156

1.61

25.37

3.6

3.9

—

Hernia

611

2589

1.61

25.36

3.7

3.8

—

Abnormalities of heart beat

188

810

2.31

25.34

3.4

3.6

—

Other systemic involvement of connective tissue

207

943

2.22

25.07

3.3

3.7

—

Gastrointestinal diseases

346

904

1.92

24.92

4.1

4.0

—

Kela reimbursement Agammaglobulinemia (D80-84)

13.64

24.88

4.6

3.2

—

Peripheral artery disease

356

1570

1.84

24.68

3.8

3.5

—

Factors influencing health status and contact with health services

219

481

2.30

24.60

4.2

3.6

—

Candidiasis

110

374

2.98

24.59

5.1

4.0

—

Benign neoplasms

620

2167

1.60

24.51

4.1

3.7

—

Cardiac arrhythmias

346

1228

1.87

24.46

3.4

4.1

—

Alcohol use disorder, Swedish definition

383

2011

1.78

24.43

3.8

3.7

—

Other immunodeficiencies

10.31

24.38

6.6

4.2

—

Dermatitis and eczema

686

2915

1.55

24.17

3.9

3.8

—

Any mental disorder

735

2397

1.54

23.96

3.8

3.9

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

7.49

23.96

4.3

3.8

—

Disorders of thyroid, IBD co-morbidities

103

237

3.19

23.96

3.9

3.7

—

Need for immunization against other single viral diseases

7.24

23.95

5.3

4.1

—

Other CVD (FINNGEN)

237

3.26

23.78

3.5

3.9

—

Other diseases of pericardium

124

4.64

23.69

3.7

4.0

—

Hypertension, essential

478

1614

1.70

23.66

3.5

3.9

—

Seropositive rheumatoid arthritis

196

893

2.21

23.61

3.9

3.7

—

Other special examinations and investigations of persons without complaint or reported diagnosis

426

1225

1.77

23.60

4.2

3.7

—

Cardiodefibrillation

300

1599

1.89

23.50

3.5

3.6

—

Other disorders of urethra and urinary system

444

1969

1.70

23.25

3.7

3.8

—

Psychiatric diseases

713

2327

1.54

23.20

3.8

3.9

—

Type 2 diabetes, wide definition

558

2271

1.61

23.12

3.2

3.8

—

Gout

229

1016

2.07

23.07

3.4

3.6

—

Malignant neoplasm

558

2063

1.61

22.83

3.4

3.8

—

Hyperlipidaemia, other/unspecified

299

1520

1.88

22.76

3.3

3.7

—

Chronic periapical parodontitis

147

603

2.46

22.74

4.2

3.7

—

Other arrhythmias

381

1667

1.76

22.72

3.5

3.9

—

Finngen Rheumatological endpoints

594

2141

1.59

22.70

3.6

3.9

—

Viral infections characterized by skin and mucous membrane lesions

271

1420

1.92

22.39

3.9

3.8

—

Hypertensive diseases

479

1630

1.67

22.34

3.5

3.9

—

Soft tissue disorders

630

2096

1.57

22.33

3.7

4.0

—

In situ neoplasms

233

1109

2.02

22.08

4.1

3.8

—

Anxiety disorders, excluding more controls

492

1999

1.64

22.06

4.0

3.9

—

Depression or dysthymia

469

1574

1.67

22.05

4.1

3.9

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

312

1719

1.82

22.00

3.9

3.6

—

Direct fill therapy

108

387

2.82

21.98

5.0

3.8

—

Pain (limb, back, neck, head abdominally)

466

1389

1.69

21.97

3.4

4.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

332

1476

1.81

21.97

3.7

3.5

—

Shoulder lesions

507

1913

1.63

21.91

3.4

3.8

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

158

4.02

21.87

2.7

3.7

—

Hypertension

476

1629

1.66

21.73

3.6

3.9

—

Viral hepatitis

182

3.74

21.54

3.5

4.3

—

389

2105

1.71

21.49

3.7

3.8

—

STROKE

380

1523

1.74

21.47

3.5

3.8

—

Symptoms and signs involving the urinary system

519

2528

1.59

21.41

3.9

3.7

—

Mental and behavioural disorders due to alcohol

340

1887

1.76

21.34

3.8

3.7

—

403

2152

1.69

21.24

3.7

3.8

—

Asthma mixed form (mode), excluding more controls

9.05

21.19

4.2

2.7

—

Chronic periodontitis, complicated

330

2.96

21.18

4.7

3.7

—

Rheumatoid arthritis

232

1064

2.00

21.16

3.9

3.8

—

Other and unspecified dermatitis

322

1815

1.78

21.13

4.1

3.8

—

Parodontitis and operation codes

547

2722

1.57

21.11

4.0

3.7

—

Sleep apnoea, including avohilmo

618

2622

1.54

21.01

3.8

—

Other dorsopathies, not elsewhere classified

630

2163

1.54

20.94

3.6

4.0

—

Enterocolitis due to Clostridium difficile

104

376

2.81

20.89

3.9

3.6

—

Cellulitis

155

678

2.31

20.81

4.1

3.7

—

Episodal and paroxysmal disorders

686

2335

1.51

20.64

3.7

3.9

—

Other diseases of urinary system

644

2386

1.52

20.60

3.6

3.8

—

Depression medications

140

271

2.61

20.59

3.5

5.5

—

Human immunodeficiency virus [HIV] disease

6.29

20.47

4.3

3.6

—

Neurological diseases, wide definition

148

296

2.52

20.33

4.0

—

Fracture of rib(s), sternum and thoracic spine

216

1086

2.01

20.29

3.5

3.6

—

Falls/tendency to fall

671

2231

1.51

20.13

3.5

4.0

—

Nonhereditary hypogammaglobulinemia

9.17

20.00

4.4

3.9

—

Mood disorders, excluding more controls

579

2290

1.54

19.99

4.0

3.9

—

Seropositive rheumatoid arthritis, strict definition

120

478

2.54

19.87

4.0

3.7

—

Sulfasalazine

157

706

2.24

19.71

3.4

—

L01XE Protein kinase inhibitors

194

3.54

19.71

3.4

3.9

—

Respiratory tuberculosis, not confirmed

157

3.86

19.66

3.9

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

143

3.97

19.66

3.5

4.1

—

Rotator cuff syndrome

402

1808

1.66

19.41

3.4

3.8

—

Gout, unspecified

173

816

2.14

19.39

3.4

3.6

—

Pulmonary eosinophilia, not elsewhere classified

7.61

19.30

4.2

3.9

—

Dermatitis

377

2278

1.66

19.26

4.0

3.8

—

Valvular heart disease excluding rheumatic fever

306

1257

1.79

19.25

3.6

3.8

—

Mental and behavioural disorders due to opioids

5.39

19.25

4.3

3.8

—

Other external causes of accidental injury

512

1619

1.59

19.24

3.5

3.8

—

Spinal stenosis

366

1705

1.69

19.18

3.7

—

Asthma mixed form (mode)

7.95

19.15

4.2

2.7

—

Seropositive rheumatoid arthritis, wide

196

974

2.03

19.06

3.9

3.6

—

Other/unspecified seropositive rheumatoid arthritis

195

968

2.03

19.02

3.8

3.6

—

Non-rheumatic valve diseases

305

1255

1.78

19.02

3.6

3.8

—

Injuries to the head

662

2929

1.48

18.81

3.5

3.9

—

Intracranial trauma

334

1452

1.72

18.72

3.5

4.1

—

Methotrexate

325

2.82

18.69

3.5

3.4

—

Cystic fibrosis

48.20

18.67

17.6

2.3

—

Other disorders of fluid, electrolyte and acid-base balance

212

1051

1.96

18.60

3.7

3.6

—

Other and unspecified iron deficiency

222

1162

1.92

18.56

3.7

3.6

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

109

429

2.57

18.56

3.3

3.9

—

Other cataract

314

1398

1.75

18.54

3.6

3.8

—

Biological medicines for asthma

8.19

18.45

5.2

3.7

—

Hernia of abdominal wall, postoperative

114

460

2.50

18.37

3.9

3.3

—

Conduction disorders

201

839

2.01

18.36

3.3

3.6

—

Depression

559

2544

1.52

18.35

4.0

3.9

—

Lung diseases due to external agents

127

540

2.38

18.31

3.8

3.5

—

Lower back pain or/and sciatica

622

2918

1.48

18.30

3.7

3.8

—

Symptoms and signs involving the skin and subcutaneous tissue

420

2631

1.60

18.20

4.0

3.8

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

235

777

1.93

18.17

4.1

4.0

—

Accidents

506

1619

1.57

18.13

3.5

3.8

—

Gout, FINNGEN

229

1223

1.89

18.08

3.4

3.5

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

190

953

2.01

18.04

3.8

3.6

—

Sequelae of tuberculosis

5.51

17.93

6.4

3.5

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

392

2428

1.62

17.91

3.7

—

Cardiomyopathy, other and unspecified

248

3.07

17.77

3.5

4.1

—

Other functional intestinal disorders

282

1531

1.76

17.77

3.9

3.7

—

Alcohol dependence

193

980

1.98

17.70

3.8

3.6

—

Benign neoplasm: Colon, unspecified

191

968

1.99

17.65

3.8

3.5

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

4.71

17.64

3.0

4.3

—

Chronic lymphocytic leukaemia, helper endpoint

4.71

17.64

3.0

4.3

—

Problems related to lifestyle

244

3.07

17.58

3.8

3.6

—

Poisoning by drugs, medicaments and biological substances

139

625

2.24

17.54

3.4

4.1

—

Benign neoplasm of other and ill-defined parts of digestive system

125

538

2.35

17.53

3.9

3.6

—

Cystitis

514

2051

1.54

17.52

3.3

3.8

—

Chronic laryngitis and laryngotracheitis

102

400

2.58

17.50

4.4

3.6

—

Iron deficiency anaemia

275

1553

1.76

17.45

3.6

—

Pneumonia derived septicemia

4.93

17.38

3.9

3.1

—

Polyneuropathies and other disorders of the peripheral nervous system

167

811

2.08

17.38

3.4

3.6

—

Deviated nasal septum

210

1105

1.91

17.29

3.6

3.5

—

Anxiety disorders

503

2338

1.53

17.26

3.9

4.0

—

Disorders of lens

453

1826

1.57

17.11

3.4

3.8

—

Diseases of the musculoskeletal system and connective tissue

300

850

1.78

17.11

3.7

4.4

—

Convulsions, not elsewhere classified

138

617

2.22

17.08

3.7

3.8

—

Any event in cancer register

537

2110

1.51

17.01

3.4

3.8

—

Atopic dermatitis

279

1363

1.75

17.00

3.9

4.0

—

Neurotic, stress-related and somatoform disorders

494

2303

1.53

16.97

4.0

—

Allergic rhinitis

160

764

2.08

16.88

3.8

4.3

—

Gout, idiopatic and unspecified

195

1012

1.95

16.85

3.4

3.6

—

Mood disorders

603

2710

1.47

16.63

3.9

—

Follow-up examination after treatment for conditions other than malignant neoplasms

258

938

1.81

16.63

3.6

—

Other and unspecified polyneuropathies, also in other diseases

150

713

2.13

16.56

3.5

3.6

—

Mood [affective] disorders

601

2706

1.46

16.55

4.0

3.9

—

Other infectious diseases

275

2.88

16.54

3.6

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

265

2.92

16.44

3.1

3.7

—

Alcohol use disorder, ICD-based

275

1602

1.73

16.25

3.8

3.6

—

Other arthritis (FG)

196

1031

1.91

16.23

3.8

—

Non-small cell lung cancer, squamous, helper endpoint

194

3.27

16.21

2.7

3.7

—

Non-small cell lung cancer, squamous

194

3.27

16.21

2.7

3.7

—

Congenital malformations of the respiratory system

5.92

16.00

4.1

3.6

—

Symptoms and signs concerning food and fluid intake

285

2.80

15.98

3.7

—

Autoimmune diseases

667

2373

1.44

15.95

3.7

3.9

—

Anxiety (asthma-related co-morbidities)

297

1385

1.70

15.94

4.0

4.1

—

External causes of morbidity and mortality

400

1250

1.61

15.92

3.8

3.9

—

Other anxiety disorders

222

1077

1.83

15.91

4.1

—

Diseases of the eye and adnexa

455

1468

1.56

15.81

3.8

4.1

—

Pleural plaque

351

2.60

15.72

3.6

3.5

—

Hypothyroidism and >3 levothyroxin purchases

106

240

2.55

15.70

3.4

4.5

—

Hypothyroidism, levothyroxine purchases

106

240

2.55

15.70

3.4

4.5

—

Benign neoplasm: Sigmoid colon

130

597

2.20

15.68

3.8

3.7

—

Functional dyspepsia

164

822

2.01

15.66

3.7

—

Carcinoma in situ of skin

240

2.97

15.63

3.9

3.8

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

327

1360

1.66

15.62

3.6

3.7

—

Osteoporosis with pathological fracture (FG)

183

3.28

15.61

3.6

3.7

—

Disorders of oesophagus in diseases classified elsewhere

5.55

15.54

6.1

3.8

—

Hypothyroidism (congenital or acquired)

106

241

2.54

15.54

3.4

4.5

—

Pericarditis

4.38

15.53

3.4

4.3

—

Other CVD

153

751

2.06

15.52

3.6

3.5

—

Hypotension

137

646

2.14

15.48

3.4

3.5

—

Defects in the complement system

12.14

15.46

4.8

2.9

—

Lymphoid leukaemia

175

3.32

15.36

3.8

3.9

—

Other disorders of veins

247

1420

1.75

15.30

3.6

3.7

—

Sequelae of external causes of morbidity and mortality

169

864

1.97

15.29

3.4

3.5

—

Polyuria

163

824

1.99

15.24

3.6

3.4

—

Poisoning by medicine

121

546

2.23

15.21

3.5

4.0

—

Cardiomyopathies, Primary/intrinsic

392

2.48

15.21

3.7

3.9

—

Deposits [accretions] on teeth

164

3.34

15.21

6.5

4.0

—

Nutritional anaemias

316

1893

1.63

15.09

3.7

3.6

—

Parodontitis or/and operation codes

385

1448

1.59

15.08

4.1

3.8

—

Carcinoma in situ of skin of other and unspecified parts of face

256

2.86

15.08

4.6

3.7

—

Endocarditis

102

4.12

15.04

3.3

4.2

—

Congenital malformations of trachea and bronchus

7.55

15.02

4.0

3.6

—

Non-selective monoamine reuptake inhibitors

249

1399

1.74

14.99

3.7

3.8

—

Irritable bowel syndrome

158

795

2.00

14.94

3.5

3.9

—

Used for control exclusion in common control thyroid runs

629

2228

1.43

14.83

3.7

3.9

—

Other specified/unspecified arthritis

172

895

1.93

14.77

3.8

3.9

—

Other noninfective gastroenteritis and colitis

155

778

2.00

14.74

4.4

3.8

—

Sicca syndrome [Sjögren]

243

2.88

14.69

3.8

3.7

—

Other disorders of white blood cells

170

3.30

14.68

4.1

—

Cardiomyopathy (excluding other)

411

2.41

14.67

3.7

3.9

—

Other disorders of teeth and supporting structures

132

627

2.12

14.62

4.1

3.8

—

Other gastritis (incl. Duodenitis)

158

804

1.98

14.52

3.6

3.5

—

Disorders of skin appendages

258

1524

1.70

14.51

4.3

3.8

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

593

2706

1.43

14.49

3.8

3.7

—

Kidney transplant status

152

3.42

14.42

4.5

4.6

—

Nausea and vomiting

162

819

1.96

14.38

4.3

3.9

—

Diseases of liver

219

1241

1.78

14.35

3.4

3.6

—

Chronic pancreatitis

101

434

2.35

14.34

6.2

3.8

—

Diseases of salivary glands

118

541

2.20

14.31

3.7

—

Personality disorders, excluding more controls

128

607

2.12

14.23

3.4

4.2

—

Other/unspecified dorsalgia

226

1289

1.75

14.20

3.6

3.8

—

Persons with potential health hazards related to communicable diseases

179

948

1.88

14.18

4.5

4.1

—

Chronic lymphocytic leukaemia

107

3.96

14.16

3.0

3.7

—

Other diseases of hard tissues of teeth

345

1627

1.59

14.14

4.4

3.8

—

Abnormal results of function studies

184

3.13

14.12

3.8

3.6

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

277

2.71

14.08

3.7

3.4

—

Non-invasive ventilation

119

516

2.18

14.02

4.4

3.9

—

Diseases of the digestive system

299

1849

1.62

14.00

4.2

3.6

—

Behavioural syndromes associated with physiological disturbances and physical factors

163

849

1.93

13.94

3.6

4.1

—

Other viral diseases

157

806

1.95

13.93

3.6

4.1

—

Wegener granulomatosis

5.51

13.84

6.1

3.7

—

In situ neoplasms

233

1359

1.72

13.82

4.1

3.6

—

Other diseases of the digestive system

221

1272

1.75

13.75

3.6

3.5

—

Any operation in hilmo

9.82

13.72

4.0

7.8

—

Ischaemic heart disease, wide definition

489

2088

1.47

13.72

3.4

3.8

—

Cutaneous abscess, furuncle and carbuncle

151

772

1.97

13.70

4.3

3.6

—

Stomatitis and related lesions

193

3.04

13.66

2.9

4.0

—

Other headache syndromes

228

1326

1.73

13.64

4.4

3.9

—

Other diseases of lip and oral mucosa

103

456

2.28

13.63

3.5

3.7

—

Overexertion and strenuous or repetitive movements

293

2.62

13.62

3.5

3.9

—

Selective deficiency of immunoglobulin G [IgG] subclasses

9.99

13.58

4.8

3.8

—

Senile cataract

414

1697

1.52

13.55

3.3

3.8

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

355

2308

1.54

13.52

3.8

3.7

—

Other inflammation of eyelid

396

2.37

13.49

3.5

3.7

—

Cerebrovascular diseases

484

2381

1.46

13.48

3.5

3.7

—

GI-bleeding

222

1287

1.74

13.47

3.6

3.5

—

Other diseases of oesophagus

331

2.51

13.39

3.9

3.7

—

Respiratory tuberculosis, clinically confirmed

5.95

13.32

4.7

3.5

—

Other disorders of eye and adnexa

386

2.38

13.31

4.9

3.9

—

Heart failure and coronary heart disease

255

1134

1.69

13.31

3.3

3.6

—

Need for other prophylactic measures

155

3.28

13.30

3.9

3.6

—

Hypertensive heart and/or renal disease

189

803

1.84

13.30

3.6

3.7

—

All anxiety disorders

298

1493

1.61

13.27

4.0

4.1

—

Rheumatoid arthritis, including avohilmo

244

1460

1.68

13.19

3.9

3.6

—

Disorders of gallbladder, biliary tract and pancreas

600

2763

1.40

13.17

4.0

3.7

—

Soft tissue disorders related to use, overuse and pressure

168

903

1.87

13.14

3.7

3.8

—

Sequelae of infectious and parasitic diseases

236

2.79

13.12

5.7

3.8

—

Atopic dermatitis, strict definition with reimbursement

138

672

2.00

13.10

3.9

4.2

—

Benign neoplasm: Transverse colon

311

2.54

13.09

3.7

3.9

—

Non-allergic asthma

259

2.69

13.05

4.0

4.3

—

Injuries to the hip and thigh

301

1737

1.59

13.01

3.6

3.7

—

Other intervertebral disc disorders

491

2074

1.45

12.96

3.6

3.8

—

Ischemic heart diseases

489

2114

1.45

12.95

3.5

3.8

—

Hard cardiovascular diseases

493

2190

1.45

12.93

3.5

3.8

—

Recurrent or chronic depression

207

846

1.77

12.92

4.2

4.3

—

Noninfective enteritis and colitis

264

1619

1.64

12.89

4.1

3.7

—

Concussion

267

1416

1.64

12.84

3.6

4.1

—

Cytomegalovirus infection, IBD co-morbidity

5.05

12.71

3.1

3.4

—

Adverse effects, not elsewhere classified

114

542

2.12

12.67

3.5

4.1

—

Other arthrosis

329

1511

1.56

12.65

3.5

3.7

—

Unspecified haematuria

283

1515

1.61

12.61

4.1

3.4

—

Lymphoid leukaemia

198

2.93

12.54

3.8

4.0

—

Dizziness and giddiness

447

2500

1.46

12.50

3.6

3.7

—

Neurological diseases

497

1730

1.45

12.49

3.7

4.0

—

Care involving dialysis

254

2.67

12.48

5.2

3.6

—

Non-follicular lymphoma, hilmo, excluding all cancers

289

2.56

12.45

3.3

3.8

—

Benign neoplasm of other and ill-defined parts of digestive system

125

620

2.03

12.44

3.9

3.6

—

Injuries to the knee and lower leg

683

2873

1.36

12.42

3.6

3.9

—

Budesonide

278

2.57

12.34

3.8

3.3

—

Noninfectious colitis NAS

406

2.29

12.33

3.6

3.8

—

Abnormalities of gait and mobility

435

2.23

12.12

3.1

3.6

—

Statin medication

389

1453

1.51

12.07

4.0

3.9

—

Dorsopathies

591

2168

1.39

12.04

3.7

4.0

—

Diabetes, varying definitions

590

2547

1.39

12.03

3.5

4.0

—

Ptosis of eyelid

355

2.37

11.99

4.1

3.7

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

130

662

1.97

11.98

3.8

4.1

—

Abnormal weight loss

301

2.49

11.95

3.8

—

Visual disturbances

275

1741

1.59

11.89

4.1

3.7

—

Angina pectoris

399

1825

1.48

11.88

3.3

3.8

—

Injury, poisoning and certain other consequences of external causes

316

1005

1.58

11.88

4.0

—

Hypertensive Heart Disease

167

750

1.83

11.87

3.6

3.7

—

Myocarditis

3.76

11.83

3.5

4.4

—

Nonorganic sleeping disorders, excluding more controls

445

2.19

11.83

3.6

4.2

—

Coagulation defects, purpura and other haemorrhagic conditions

122

612

2.01

11.78

3.4

3.7

—

Other viral diseases, not elsewhere classified

107

510

2.11

11.76

3.7

4.0

—

Unspecified human immunodeficiency virus [HIV] disease

6.63

11.66

5.2

3.4

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

234

1423

1.64

11.61

3.5

3.7

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

330

1475

1.53

11.61

3.7

3.8

—

Weight loss

324

2.41

11.56

3.8

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

123

3.40

11.55

2.9

3.9

—

Drug-induced osteoporosis with pathological fracture

5.01

11.55

3.4

3.5

—

282

1700

1.57

11.51

3.9

3.5

—

Acetic acid derivatives and related substances

196

577

1.78

11.50

3.3

4.4

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

300

1330

1.56

11.48

3.7

—

Hereditary hypogammaglobulinemia

22.58

11.46

5.1

3.0

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

302

1340

1.56

11.38

3.7

—

Sequelae with surgical and medical care as external cause

133

698

1.92

11.30

3.3

3.6

—

Pneumococcal septicemia

101

3.64

11.24

3.8

4.0

—

Sleep disorders

119

603

1.99

11.18

3.5

4.0

—

Actinic keratosis

262

1579

1.58

11.18

3.9

3.5

—

Other diseases of anus and rectum

182

1053

1.74

11.18

3.9

3.6

—

Dental caries 1 and operation codes

535

1967

1.40

11.15

3.6

3.7

—

Dental caries 3 and operation codes

554

2050

1.39

11.13

3.7

—

Benign neoplasm: Sigmoid colon

130

681

1.93

11.12

3.8

3.6

—

Selective serotonin reuptake inhibitors

594

2284

1.37

11.11

3.8

3.9

—

Other reaction to severe stress, and adjustment disorders

170

967

1.76

11.10

4.6

4.0

—

Cytomegaloviral disease

4.36

11.09

3.1

4.1

—

Heart failure and hypertrophic cardiomyopathy

4.65

11.06

3.3

3.6

—

Diabetes mellitus

585

2556

1.37

11.05

3.5

4.0

—

Conjunctivitis (acute, non atopic)

146

792

1.85

11.05

3.7

4.0

—

AV-block

117

535

2.00

11.02

3.0

3.7

—

Other disorders of adrenal gland

112

3.45

11.00

5.2

3.6

—

Hypo-osmolality and hyponatraemia

116

585

1.99

10.98

3.7

—

Other and unspecified effects of external causes

142

769

1.86

10.93

3.9

4.0

—

Skin changes due to chronic exposure to nonionizing radiation

267

1622

1.57

10.85

3.9

3.5

—

Benign neoplasm: Other and unspecified parts of small intestine

4.87

10.81

5.8

3.4

—

Antihypertensive medication - note that there are other indications

266

912

1.60

10.80

4.5

4.6

—

Fracture of lumbar spine and pelvis

143

780

1.84

10.75

3.5

3.6

—

Hypertension, Pulmonary Arterial

6.86

10.74

3.3

3.4

—

Gangrene, not elsewhere classified

8.64

10.71

2.9

3.1

—

Paralytic ileus and intestinal obstruction

161

913

1.77

10.66

3.9

3.5

—

Glomerular diseases

121

628

1.94

10.65

4.0

3.4

—

Benign neoplasm: Ascending colon

400

2.20

10.64

3.8

3.9

—

Respiratory disorders in diseases classified elsewhere

5.19

10.62

5.5

3.6

—

Benign neoplasm: Small intestine

125

3.27

10.59

5.3

3.4

—

Ethmoidectomy

375

2.23

10.58

6.2

3.6

—

Carrier of infectious disease

4.43

10.57

5.5

3.4

—

Melanocytic naevi

146

807

1.82

10.54

3.8

3.9

—

Pain in thoracic spine

408

2.17

10.52

3.6

4.1

—

Atopic dermatitis, strict definition

127

658

1.90

10.51

3.9

4.4

—

Benign neoplasm: Rectum, anus and anal canal

125

660

1.91

10.46

3.2

3.8

—

Subjective visual disturbances

142

781

1.83

10.44

3.6

3.7

—

Trochanteric bursitis

404

2.17

10.38

3.9

—

Memory loss

360

2.25

10.35

3.8

3.7

—

Recurring oral aphthae, including avohilmo

411

2.16

10.35

3.6

3.7

—

Other and unspecified disorders of white blood cells

132

3.17

10.35

4.0

3.7

—

Genitourinary diseases

350

1178

1.49

10.31

4.0

4.1

—

Other or unspecified immunodeficiency

11.93

10.30

9.5

3.4

—

Disorder of lipoprotein metabolism, unspecified

100

492

2.05

10.28

3.1

3.7

—

Injuries to the wrist and hand

539

2873

1.36

10.27

4.2

3.8

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

268

2.45

10.25

3.7

3.9

—

Disturbances of skin sensation

142

786

1.82

10.23

3.7

3.8

—

Sequelae of injuries, of poisoning and of other consequences of external causes

137

751

1.83

10.20

3.6

3.9

—

Unspecified fall

281

1841

1.52

10.13

3.8

—

Cervicalgia

122

647

1.90

10.08

3.4

3.9

—

Exposure to other specified factors

388

2557

1.43

10.08

3.8

3.9

—

Mental and behavioural disorders due to sedatives or hypnotics

172

2.82

10.02

3.4

4.0

—

Visual disturbances and blindness

289

1926

1.51

9.99

4.1

3.7

—

Other complications of surgical and medical care, not elsewhere classified

290

2.37

9.96

4.3

4.0

—

Disorders of lacrimal system

233

1483

1.58

9.95

3.5

3.8

—

Adrenocortical insufficiency

3.54

9.93

5.6

3.6

—

Benign neoplasm of mouth and pharynx

309

2.32

9.93

4.1

—

Unspecified kidney failure

367

2.20

9.89

3.1

3.6

—

Other/unspecified cytomegaloviral diseases

4.49

9.87

3.3

3.7

—

Abnormal findings on diagnostic imaging of other body structures

285

2.37

9.86

5.8

3.4

—

Pollen allergy

363

2.19

9.82

4.1

4.5

—

Herpesviral [herpes simplex] infections

323

2.28

9.82

3.9

—

Other disorders of lacrimal gland

191

1163

1.65

9.80

3.3

3.8

—

Personality disorders

128

696

1.85

9.78

3.4

4.1

—

Other and unspecified drugs and medicaments

250

2.47

9.76

3.4

4.0

—

Dental caries, including avohilmo

479

1765

1.39

9.74

3.5

3.7

—

Dental caries 1

479

1766

1.39

9.70

3.5

3.7

—

Fibromyalgia

175

2.77

9.69

3.4

3.7

—

N06DA Anticholinesterases

1248

0.47

9.65

3.3

3.5

—

Use of anticholinesterases

1248

0.47

9.65

3.3

3.5

—

Fentanyl

313

2.29

9.63

3.1

3.6

—

Polypectomy (DHB20)

234

2.51

9.62

4.4

3.8

—

Sequelae of injuries of lower limb

270

2.39

9.61

3.2

4.1

—

Suicide or other Intentional self-harm

127

693

1.84

9.61

3.8

4.0

—

Disorders of synovium and tendon

277

1658

1.51

9.58

3.6

3.9

—

Tuberculosis of other organs

3.89

9.57

5.1

3.5

—

Other nutritional deficiencies

325

2187

1.46

9.52

3.4

3.8

—

Other disorders of eyelid

276

1778

1.51

9.51

3.8

3.7

—

FESS (DNB20)

354

2.19

9.46

6.0

3.6

—

Coronary atherosclerosis

424

1956

1.40

9.46

3.6

3.8

—

Giant cell arteritis

145

2.95

9.44

3.7

—

Common variable immunodeficiency

9.01

9.43

4.7

3.7

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

167

2.80

9.43

3.2

4.0

—

Sciatica+with lumbago

272

1719

1.51

9.41

3.7

3.8

—

ILD and respiratory illness in diseases classified elsewhere

8.20

9.41

2.7

4.4

—

Disorders of other endocrine glands

231

1463

1.56

9.38

4.0

3.9

—

Type 2 diabetes

561

2489

1.34

9.38

3.3

3.9

—

Ocular pain

213

2.56

9.37

5.4

3.5

—

Dental caries 3

501

1873

1.37

9.35

3.6

3.7

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

422

2.08

9.32

4.4

3.6

—

Other specified/unspecified systemic involvement of connective tissue

168

2.77

9.30

3.1

3.5

—

Volume depletion

306

2.28

9.27

3.5

3.7

—

Follicular cysts of skin and subcutaneous tissue

112

595

1.89

9.26

4.3

3.7

—

Carcinoma in situ of skin

313

2.27

9.26

3.9

3.7

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

3.58

9.25

4.4

3.8

—

Missing teeth due to accident, extraction or parodontitis

332

2.22

9.22

3.6

3.9

—

Benign neoplasm: Rectum

109

575

1.91

9.22

3.3

3.7

—

Diseases of pulp and periapical tissues, including avohilmo

622

2449

1.32

9.20

3.9

—

Carcinoma in situ of skin of other and unspecified parts of face

327

2.23

9.18

4.6

3.7

—

Cervical disc disorders

216

1378

1.57

9.18

3.9

3.8

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

142

2.94

9.17

2.9

4.0

—

Temporal arteritis

132

3.02

9.10

3.8

3.6

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

544

2486

1.34

9.08

3.4

3.9

—

Eosinophilic disease (BM)

15.90

9.07

4.4

2.8

—

Benign neoplasm: Other and unspecified parts of small intestine

4.21

9.07

5.8

3.9

—

Presence of cardiac and vascular implants and grafts

307

1588

1.47

9.06

3.3

3.6

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

400

2.09

9.04

3.7

4.1

—

Zoster [herpes zoster]

113

607

1.87

9.04

4.0

3.6

—

Intestinal adhesions without obstruction

266

2.36

9.01

3.8

—

Reactive arthropathies, FINNGEN

194

2.60

8.99

4.5

4.1

—

Superficial injury of thorax

490

1.97

8.96

3.4

3.7

—

Drug-induced osteoporosis

4.84

8.92

3.5

3.7

—

Oesophagitis

178

2.68

8.89

4.6

3.9

—

Secondary hypertension

159

2.76

8.88

3.6

3.8

—

Other bacterial agents as the cause of diseases classified to other chapters

5.94

8.88

8.5

4.2

—

Transport accidents

223

1275

1.55

8.88

3.9

—

Obesity, other/unspecified

163

979

1.67

8.86

3.0

3.9

—

Dental pulpitis 1

621

2460

1.31

8.84

3.9

—

Insulin medication

358

2172

1.41

8.79

3.5

3.8

—

Type 2 diabetes, strict (exclude DM1)

547

2457

1.33

8.78

3.4

3.9

—

Type 2 diabetes, definitions combined, including avohilmo

546

2431

1.33

8.77

3.4

3.8

—

Benign neoplasm: Caecum

301

2.25

8.76

3.8

—

Extracorporeal dialysis

197

2.57

8.75

5.0

4.2

—

Type 2 diabetes, definitions combined

542

2432

1.33

8.74

3.4

3.9

—

Dental pulpitis 4

620

2459

1.31

8.74

3.9

—

Retention of urine

224

1227

1.55

8.71

4.1

3.4

—

Carcinoma in situ of skin of trunk

3.31

8.68

3.9

4.2

—

Mental and behavioural disorders due to tobacco

246

2.38

8.66

4.6

4.1

—

Injuries to the shoulder and upper arm

471

2938

1.35

8.62

3.5

3.9

—

Injuries to the ankle and foot

330

2114

1.43

8.59

4.0

3.9

—

Smoking dependency

247

2.37

8.59

4.6

4.1

—

Other neurological diseases

433

2558

1.36

8.56

3.3

3.7

—

Special screening examination for neoplasms

142

2.86

8.56

4.2

3.4

—

8.05

8.53

2.8

3.8

—

Drug-induced adrenocortical insufficiency

4.27

8.52

4.6

3.5

—

Mixed connective tissue disease

182

2.61

8.51

4.0

3.6

—

Gout, strict definition

128

729

1.77

8.51

3.2

3.6

—

Diabetes medication

573

2652

1.32

8.50

3.4

3.9

—

Pyogenic arthritis

230

2.42

8.49

3.2

4.1

—

Somatoform disorder

458

1.98

8.48

3.2

4.1

—

Benign neoplasm: Small intestine

143

2.85

8.48

5.2

3.4

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

116

3.08

8.48

3.3

3.4

—

Dementia in Alzheimer disease

725

0.34

8.48

2.8

3.4

—

Other disorders of the musculoskeletal system and connective tissue

507

1.93

8.48

3.2

3.8

—

Nonorganic sleeping disorders

507

1.92

8.45

3.6

4.0

—

Tuberculosis of other organs, strict

3.45

8.40

5.1

3.4

—

Systemic lupus erythematosus

101

3.22

8.39

2.5

3.6

—

Haemolytic anaemias

3.29

8.38

3.1

3.7

—

Gastroduodenal ulcer

165

1008

1.64

8.36

3.6

3.5

—

Dental pulpitis 2

430

1602

1.38

8.36

3.7

3.8

—

Fracture at wrist and hand level

179

1118

1.61

8.34

4.1

3.8

—

Giant cell arteritis with polymyalgia rheumatica

139

2.86

8.33

3.8

3.6

—

Personal history of allergy to drugs, medicaments and biological substances

5.51

8.27

6.1

2.9

—

Pain and other conditions associated with female genital organs and menstrual cycle

396

2.02

8.27

4.0

4.2

—

5-aminosalicylic acid

469

1.95

8.26

3.6

3.7

—

Fall on same level involving ice and snow

307

2153

1.43

8.26

3.6

3.8

—

Benign neoplasm: Transverse colon

382

2.06

8.23

3.7

—

Haemorrhage, not elsewhere classified

118

3.02

8.23

3.4

3.2

—

Discitis, unspecified

4.47

8.21

3.0

4.1

—

Lumbar disc prolapse

341

1928

1.41

8.20

3.7

3.8

—

Benign neoplasm of middle ear and respiratory system

240

2.36

8.19

4.9

4.0

—

Biological medication for rheuma

403

2.02

8.15

3.9

4.1

—

Major coronary heart disease event excluding revascularizations

418

2119

1.37

8.14

3.3

3.7

—

SLE (Finngen)

103

3.16

8.13

2.5

4.0

—

Melanocytic naevi of trunk

304

2.19

8.13

3.3

4.1

—

Open wound of head

297

2045

1.43

8.13

3.3

3.8

—

Migraine with aura

100

535

1.88

8.12

4.7

4.1

—

Other symptoms and signs involving cognitive functions and awareness

271

1746

1.46

8.10

3.5

3.7

—

Papulosquamous disorders

219

1444

1.52

8.09

3.5

3.7

—

Gonarthrosis [arthrosis of knee](FG)

437

1899

1.36

8.00

3.3

3.7

—

Dental pulpitis 2, only avohilmo

436

1640

1.36

7.99

3.6

3.8

—

Assault

307

2.16

7.94

4.6

4.3

—

Other inflammatory liver diseases

201

2.47

7.91

3.0

4.0

—

Disorders of adult personality and behaviour

127

737

1.73

7.90

3.3

4.2

—

SLE, ICD10

100

3.15

7.86

2.5

3.5

—

SLE, strict definition

100

3.15

7.86

2.5

3.5

—

Non-follicular lymphoma

356

2.07

7.81

3.3

3.6

—

Other extrapyramidal and movement disorders in other diseases

132

779

1.70

7.76

3.7

3.5

—

Insomnia

425

1.96

7.73

3.2

4.0

—

Lesion of lateral popliteal nerve

151

2.68

7.66

3.2

4.3

—

Obesity and other hyperalimentation

300

2103

1.42

7.66

3.2

3.8

—

Nerve, nerve root and plexus disorders

593

2896

1.29

7.65

3.4

3.8

—

Major coronary heart disease event

445

2223

1.34

7.63

3.3

3.7

—

Dental operations

410

1544

1.37

7.62

3.6

3.7

—

Glomerulonephritis

333

2.09

7.59

3.6

3.8

—

Obesity

298

2094

1.41

7.55

3.3

3.8

—

Sequelae of other external causes

158

2.63

7.54

3.4

—

Superficial injury of head

120

696

1.73

7.51

3.5

3.9

—

Disorders resulting from impaired renal tubular function

114

2.95

7.47

3.4

3.6

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

130

772

1.69

7.46

3.8

4.0

—

Other and unspecified coagulation defects

114

2.93

7.45

3.2

3.8

—

Myocardial infarction

315

1612

1.41

7.44

3.2

3.7

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

17.64

7.44

5.0

3.4

—

Preparatory care for dialysis

148

2.68

7.42

4.2

4.1

—

Urticaria and erythema

174

1113

1.57

7.41

3.8

—

Other joint disorders

455

1820

1.33

7.34

3.6

4.0

—

Alcohol-induced chronic pancreatitis

221

2.34

7.33

3.2

4.1

—

Use of donepezil

854

0.40

7.32

3.3

3.4

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

149

2.66

7.32

2.8

4.0

—

Other embolism and thrombosis

448

1.91

7.31

3.4

3.7

—

Coxibs

174

579

1.61

7.30

3.7

4.4

—

Diabetes, insulin treatment (Kela reimbursement)

569

2709

1.29

7.27

3.4

3.9

—

Radiculopathy

104

585

1.79

7.27

3.4

3.6

—

Other disorders of ear

528

2717

1.30

7.27

4.3

3.7

—

Other (not insulin) diabetes medications

544

2540

1.29

7.21

3.2

3.8

—

Ischaemic Stroke, excluding all haemorrhages

356

1972

1.37

7.20

3.5

3.6

—

Other specified/unspecified bacterial intestinal infections

198

2.40

7.20

3.6

3.9

—

Osteonecrosis

168

2.53

7.18

4.1

3.4

—

Personal history of allergy to analgesic agent

8.03

7.18

5.4

2.8

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

106

2.97

7.15

4.6

3.7

—

Fenamates

335

1.88

7.13

3.5

4.3

—

Arthropathies

472

1820

1.32

7.12

3.7

4.0

—

Erosion of teeth

5.75

7.09

11.4

7.6

—

Intracranial injury

310

2165

1.39

7.06

3.5

3.8

—

Tumor necrosis factor alpha inhibitors

356

2.01

7.06

3.9

4.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

349

2022

1.37

7.05

3.6

—

Other/unspecified reactive arthropathies

194

2.40

7.03

4.6

4.0

—

Benign neoplasm: Rectum, anus and anal canal

125

748

1.68

7.03

3.2

3.6

—

Peripheral arterial reconstruction

121

718

1.70

7.03

3.3

3.6

—

Migraine

199

1123

1.51

7.03

4.0

4.1

—

Dental caries 1, only avohilmo

481

1873

1.32

7.03

3.5

3.8

—

Fracture of femur

167

977

1.57

7.01

3.2

3.7

—

Melanocytic naevi

146

909

1.61

7.01

3.8

—

Other benign neoplasms of skin

191

1241

1.52

6.96

4.0

3.8

—

Other disorders of kidney and ureter

456

1.88

6.96

3.5

3.7

—

Other or ill-defined heart diseases

147

2.61

6.95

3.7

4.2

—

Superficial injury of lower leg

122

728

1.68

6.92

3.6

4.0

—

Faecal incontinence

246

2.21

6.91

4.1

3.6

—

Carcinoma in situ of skin of trunk

114

2.87

6.90

3.9

3.6

—

Stroke, including SAH

387

2143

1.34

6.84

3.5

3.7

—

Rash and other nonspecific skin eruption

293

2.10

6.83

3.6

3.9

—

Progressive vascular leukoencephalopathy

109

2.90

6.83

2.8

3.7

—

Insulin, combination of fast acting with intermediate-acting or long-acting

358

2454

1.35

6.80

3.5

3.7

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

539

1.79

6.80

4.3

3.6

—

Gastric ulcer

112

657

1.71

6.79

3.5

3.4

—

Benign neoplasm: Ascending colon

475

1.85

6.75

3.8

3.6

—

Postmenopausal bleeding

154

526

1.62

6.71

3.6

3.8

—

Deforming dorsopathies

144

904

1.60

6.70

3.9

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

151

957

1.58

6.69

3.5

4.2

—

Acute pharyngitis

313

2.04

6.68

2.9

3.6

—

Disorder of external ear, unspecified

3.03

6.68

3.8

3.4

—

Congenital malformations, deformations and chromosomal abnormalities

263

1788

1.41

6.68

3.8

4.1

—

Other specified/unspecified necrotizing vasculopathies

4.11

6.68

4.7

3.9

—

Aortic aneurysm

153

959

1.58

6.66

3.1

3.5

—

Mental and behavioural disorders due to cannabinoids

4.04

6.63

2.3

3.8

—

Other specified and unspecified personality disorders

212

2.28

6.62

3.7

4.3

—

Abnormal serum enzyme levels

193

1280

1.50

6.61

4.3

3.5

—

Other orthopaedic follow-up care

157

2.51

6.61

3.8

4.1

—

Carcinoma in situ of skin of upper limb, including shoulder

3.41

6.60

4.8

3.6

—

Injuries to unspecified part of trunk, limb or body region

311

2.04

6.58

3.9

3.8

—

Intracranial and intraspinal abscess and granuloma

4.47

6.55

3.0

3.6

—

Dentofacial anomalies [including malocclusion]

110

641

1.70

6.55

3.9

—

Other disorders of bone

567

1.75

6.54

3.4

3.9

—

Calcific aortic valvular stenosis, including rheumatic fever

193

1271

1.49

6.54

3.2

3.6

—

Agranulocytosis

339

1.99

6.54

3.2

3.7

—

Systemic lupus erythematosus, unspecified

3.05

6.53

2.4

3.5

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

5.29

6.51

5.9

5.5

—

Basal cell carcinoma, including avohilmo

358

2105

1.34

6.51

3.6

—

Hypothyroidism, drug reimbursement

166

2.25

6.50

3.2

4.3

—

Operations 2 for CAVS

192

1266

1.49

6.50

3.2

3.5

—

Calcific aortic valvular stenosis, diagnosis (helper)

192

1266

1.49

6.50

3.2

3.5

—

Calcific aortic valvular stenosis

192

1267

1.49

6.47

3.2

3.5

—

Calcific aortic valvular stenosis, operated

192

1267

1.49

6.47

3.2

3.5

—

Viral warts

273

2.10

6.45

4.0

3.8

—

Hypoparathyroidism

124

2.71

6.44

4.2

3.6

—

Stroke, excluding SAH

369

2059

1.34

6.40

3.5

3.6

—

Dental caries 3, only avohilmo

496

1967

1.29

6.39

3.6

3.8

—

Multiple myeloma and malignant plasma cell neoplasms

148

2.53

6.38

2.8

4.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

288

2.07

6.37

2.8

4.0

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

223

1360

1.44

6.36

3.3

3.7

—

Unspecific neurodegenerative disorder

127

1393

0.63

6.34

3.2

3.5

—

Other diseases of liver

558

1.75

6.34

3.3

3.7

—

Diseases of the ear and mastoid process

633

2562

1.25

6.32

4.2

3.8

—

Acquired haemolytic anaemia

3.40

6.31

2.8

4.0

—

Malignant immunoproliferative diseases

4.83

6.27

5.4

3.8

—

Acute pancreatitis

117

711

1.65

6.25

3.6

—

Persistent mood disorders

101

590

1.72

6.25

4.2

3.8

—

Infections with a predominantly sexual mode of transmission

122

749

1.63

6.22

4.2

4.1

—

Otitis externa

112

674

1.67

6.21

3.4

3.8

—

Malignant neoplasm of skin

383

2189

1.32

6.20

3.6

—

Dental operations, only avohilmo

427

1670

1.31

6.19

3.7

—

Purpura and other haemorrhagic conditions

445

1.83

6.19

3.5

3.8

—

Benign neoplasm of mouth and pharynx

374

1.91

6.19

4.1

3.9

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

121

2.69

6.18

3.9

3.0

—

Polyarthrosis

113

654

1.66

6.16

3.5

3.8

—

Hypertrophic cardiomyopathy

133

2.59

6.15

3.6

3.5

—

Basal cell carcinoma

348

2082

1.34

6.14

3.6

—

Exclusions for E4_PCOS_BROAD

490

1.78

6.11

4.1

3.9

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

116

2.71

6.10

4.2

4.0

—

Fibroblastic disorders

137

871

1.58

6.10

3.4

3.6

—

Other skin changes

580

1.72

6.09

4.3

3.6

—

Excessive attrition of teeth

175

623

1.53

6.09

4.2

3.9

—

Gonarthrosis

368

1588

1.33

6.06

3.3

3.7

—

Inguinal hernia, bilateral

391

1.88

6.06

3.8

3.7

—

Non-Hodgkin lymphoma, all

152

2.47

6.06

2.8

4.1

—

Other and specified injuries of hip and thigh

3.21

6.06

6.1

3.4

—

Psoriasis

151

983

1.54

6.05

3.3

3.8

—

Cholera

134

2.57

6.05

2.7

3.3

—

Other or unspecified ileus, impaction or obstruction

106

634

1.68

6.02

4.0

3.5

—

Other and unspecified injuries of head

177

2.34

6.00

3.8

—

Inguinal hernia

336

1692

1.34

5.99

3.7

—

Inguinal or femoral hernia, bilateral

400

1.86

5.98

3.8

3.7

—

Dental pulpitis 4, only avohilmo

613

2571

1.25

5.95

3.7

3.9

—

Amputation of toe

263

2.08

5.91

4.0

3.5

—

Benign neoplasm: Tongue

2.99

5.87

3.0

3.5

—

Fall on and from stairs and steps

133

848

1.58

5.86

3.8

3.7

—

Paracetamol of NSAID medication

262

1.79

5.84

3.8

5.5

—

ILD medications: acetylcysteine

5.64

5.84

3.7

2.7

—

Other congenital malformations, not elsewhere classified

11.44

5.83

10.6

2.4

—

Benign neoplasm of middle ear and respiratory system

278

2.03

5.82

4.9

3.9

—

Injuries to the elbow and forearm

344

2355

1.32

5.82

4.2

3.9

—

Melanocytic naevi of trunk

347

1.91

5.81

3.3

3.9

—

Transient ischemic attack

318

1972

1.34

5.81

3.3

3.6

—

Psoriatic and enteropathic arthropathies

326

1.94

5.80

3.2

3.7

—

Anaemia in chronic diseases classified elsewhere

3.12

5.80

3.0

4.0

—

Disorders of sclera, cornea, iris and ciliary body

277

2039

1.36

5.77

3.8

3.9

—

Seborrhoeic keratosis

133

852

1.57

5.76

3.8

3.6

—

Other and unspecified tonsillitis

122

645

1.61

5.76

3.7

4.1

—

Other and unspecified psoriasis

206

2.21

5.76

3.4

4.0

—

Benign neoplasm: Rectum

109

666

1.65

5.75

3.3

3.6

—

Other diseases of pancreas

266

2.05

5.74

3.4

3.9

—

Other general symptoms and signs

107

2.70

5.73

3.8

3.4

—

Diseases of external ear

176

1200

1.47

5.68

3.7

—

Biguanides

527

2589

1.26

5.67

3.1

3.8

—

Other and unspecified disorders of vitreous body

224

1589

1.41

5.67

4.2

3.6

—

Alcohol abuse, main dg, excluding more controls

407

1.83

5.66

3.5

3.7

—

Intestinal stricture

174

1185

1.47

5.66

3.7

3.6

—

Alzheimer disease, including avohilmo

104

1212

0.62

5.62

3.1

3.5

—

Mixed and other personality disorders

176

2.29

5.62

3.1

4.4

—

Polymyalgia rheumatica

482

1.76

5.60

3.0

3.5

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

145

517

1.56

5.60

3.3

3.9

—

Other and unspecified local infections of skin and subcutaneous tissue

296

1.97

5.59

3.7

—

Striking against or struck by other objects

153

1017

1.51

5.59

4.2

4.1

—

Reactive arthropathies

262

2.04

5.57

4.5

4.1

—

Diffuse large B-cell lymphoma, helper endpoint

146

2.43

5.57

3.8

3.7

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

146

2.43

5.57

3.8

3.7

—

Other metabolic disorders

331

1.91

5.56

3.5

4.0

—

Pneumoconiosis due to asbestos and other mineral fibres

3.04

5.56

3.4

—

Myocardial infarction, strict

285

1537

1.36

5.56

3.2

3.7

—

Contusion of toe(s) with damage to nail

5.36

5.55

3.6

3.5

—

Acute alcohol intoxication

139

908

1.54

5.53

3.2

3.6

—

Other local infections of skin and subcutaneous tissue

318

1.93

5.53

3.7

—

Specific personality disorders

590

1.67

5.47

3.5

4.2

—

Urticaria

133

863

1.55

5.45

4.0

3.9

—

Hypoplasia of dental enamel, including avohilmo

16.38

5.44

13.9

2.8

—

Dental pulpitis 1, only avohilmo

609

2581

1.23

5.43

3.7

3.9

—

Molar incisor enamel hypoplasia, with caries

16.36

5.43

13.9

4.2

—

Glucagon-like peptide-1 (GLP-1) analogues

334

2093

1.32

5.41

3.4

3.8

—

Acute pancreatitis (for exclusion)

117

739

1.59

5.41

3.6

—

Disorders of choroid and retina

456

2629

1.27

5.37

3.7

—

Trigger finger

429

1.78

5.37

3.6

3.8

—

Calculus of kidney and ureter

174

1200

1.46

5.33

3.4

3.5

—

Nephrotic syndrome

2.82

5.33

3.5

4.8

—

Rheumatism, unspecified

401

1.80

5.32

4.0

3.9

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

125

2.51

5.30

4.2

3.5

—

Other and unspecified visual disturbances

281

1.97

5.30

3.4

3.7

—

Hyperkalaemia

181

2.23

5.30

4.0

3.8

—

Peripheral artery operations in Hilmo

498

1.72

5.28

3.8

3.6

—

Other disorders involving the immune mechanism, not elsewhere classified

2.86

5.27

3.8

4.6

—

Recurring oral aphthae

138

2.42

5.23

2.5

3.6

—

Scleritis and episcleritis

157

2.31

5.19

3.3

3.7

—

Arterial embolism and thrombosis

209

2.12

5.17

2.5

3.3

—

Other diseases of intestine

405

1.79

5.17

3.8

—

General examination and investigation of persons without complaint and reported diagnosis

306

1221

1.34

5.16

4.0

3.7

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

434

1.76

5.14

3.7

—

Coxarthrosis [arthrosis of hip](FG)

305

1668

1.33

5.14

3.5

3.7

—

Barrett oesophagus

158

2.31

5.14

3.3

4.2

—

Myalgia

105

655

1.61

5.13

3.6

3.9

—

Squamous cell neoplasms and carcinomas of the skin

518

1.69

5.12

4.4

3.5

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

158

2.30

5.12

3.6

—

Molar incisor enamel hypoplasia

4.56

5.11

10.8

4.8

—

Diseases of tongue

165

2.26

5.08

3.7

4.3

—

Tobacco use

140

2.38

5.07

2.7

3.9

—

Respiratory conditions due to other external agents

2.96

5.07

3.0

3.9

—

Acute bronchiolitis

2.89

5.06

7.9

4.5

—

Other maltreatment syndromes

2.93

5.05

4.3

3.8

—

Malignant immunoproliferative diseases

4.02

5.04

5.4

4.6

—

Use of other anti-dementia drugs

1027

0.57

5.03

3.2

3.5

—

Use of memantine

1027

0.57

5.03

3.2

3.5

—

Adalimumab

218

2.08

5.03

4.0

4.2

—

Elevated blood glucose level

259

1.98

5.02

3.4

3.7

—

Carcinoma in situ of skin of upper limb, including shoulder

2.86

5.02

4.8

3.8

—

Collagenous colitis

273

1.96

5.01

4.6

3.9

—

Alcohol withdrawal state with delirium

239

2.03

5.00

3.1

4.0

—

Disorders of mineral metabolism

253

1.99

4.98

4.6

4.1

—

Fracture of foot, except ankle

108

684

1.58

4.97

3.7

4.1

—

Coxarthrosis

285

1453

1.33

4.97

3.5

3.7

—

Pacemaker

203

1418

1.40

4.96

3.4

3.6

—

Benign neoplasm: Caecum

374

1.81

4.96

3.8

3.6

—

Other aneurysm

193

2.15

4.96

3.4

3.1

—

Other enthesopathies

145

980

1.48

4.95

3.8

3.9

—

Glomerular disorders in diseases classified elsewhere

411

1.76

4.94

4.3

3.5

—

Fissure and fistula of anal and rectal regions

122

796

1.54

4.93

4.0

3.8

—

Hypoplasia of dental enamel , including avohilmo

4.76

4.93

11.5

4.3

—

Pneumonitis due to solids and liquids

296

1.91

4.92

4.1

3.5

—

Benign neoplasm: Adrenal gland

214

2.07

4.89

3.0

3.9

—

Episcleritis

124

2.44

4.89

3.3

3.8

—

Sleep disorders, other/unspecified

2.95

4.88

5.1

4.0

—

Meniscus derangement

303

1578

1.32

4.86

3.5

3.7

—

Nonsuppurative otitis media

505

1.63

4.83

4.3

4.5

—

Right bundle-branch block

107

2.55

4.81

3.2

4.1

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

202

2.10

4.81

3.7

3.9

—

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

3.33

4.78

2.2

3.3

—

Diffuse large B-cell lymphoma

157

2.26

4.77

3.8

3.9

—

Pruritus

299

1.88

4.77

2.8

3.6

—

Psoriatic arthropathies

292

1.89

4.77

3.2

4.0

—

Arthrosis

385

1659

1.28

4.76

3.3

3.7

—

Acute suppurative otitis media

542

1.62

4.76

5.2

4.6

—

Other diseases of blood and blood-forming organs

230

2.02

4.76

3.2

3.7

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.82

4.73

3.9

4.5

—

Other specified and unspecified disorders of eye and adnexa

120

2.45

4.73

4.4

3.7

—

Other coagulation defects

190

2.12

4.73

3.1

3.6

—

Multiple myeloma and malignant plasma cell neoplasms

171

2.19

4.70

2.8

3.9

—

Vascular disorders of the intestines

231

2.01

4.70

3.2

3.8

—

Infection of intervertebral disc (pyogenic)

3.77

4.68

4.9

3.4

—

Disorders of vitreous body

263

1946

1.33

4.68

4.2

3.6

—

Open wound of forearm

273

1.92

4.67

3.2

3.7

—

Amputation

359

1.79

4.67

3.8

3.3

—

Fracture of skull and facial bones

102

648

1.58

4.66

3.8

4.0

—

Propionic acid derivatives

170

590

1.45

4.65

3.4

4.7

—

Myocardial infarction, without ST-elevation

245

1691

1.34

4.65

3.2

3.5

—

Localized swelling, mass and lump of skin and subcutaneous tissue

156

1084

1.44

4.65

4.2

3.6

—

Abscess of anal and rectal regions

225

2.01

4.65

3.1

4.1

—

Erosion of teeth, including avohilmo

447

1.69

4.65

4.7

3.9

—

Exposure to other and unspecified animate mechanical forces

3.24

4.62

4.9

4.2

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

457

1.69

4.62

2.8

3.9

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

2.71

4.60

4.0

3.6

—

Benign neoplasm: Tongue

2.59

4.58

3.0

3.7

—

Allergic urticaria

206

2.05

4.57

4.0

3.5

—

Disorders of plasma-protein metabolism, not elsewhere classified

4.92

4.57

2.3

3.1

—

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

4.91

4.57

3.3

5.2

—

Mouth breathing

204

1489

1.37

4.57

3.4

3.8

—

Other/unspecified rheumatoid arthritis

437

1.70

4.54

4.0

3.6

—

Bacterial, viral and other infectious agents

248

1.95

4.53

5.7

4.2

—

Other hammer toe(s) (acquired)

582

1.59

4.52

3.8

—

Toxic liver disease

3.33

4.50

3.7

3.6

—

Other specified/unspecified dorsopathies

2.67

4.50

2.9

3.5

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

2.56

4.49

3.7

3.1

—

Cardiac murmurs and other cardiac sounds

140

2.27

4.48

5.0

4.1

—

Bicipital tendinitis

149

2.24

4.44

2.9

4.3

—

Fracture of lower leg, including ankle

272

2074

1.31

4.44

3.3

3.9

—

Foreign body in respiratory tract

130

2.33

4.43

3.1

4.3

—

Other arterial embolism and thrombosis

2.65

4.41

2.6

3.6

—

Urolithiasis

183

1323

1.39

4.39

3.3

3.5

—

Insulin, fast-acting

181

1305

1.39

4.39

3.9

3.7

—

Other infective otitis externa

176

2.12

4.39

3.1

4.0

—

Anosmia

3.40

4.39

3.1

3.9

—

Exclusions for E4_PCOS_CONSORTIUM

317

1542

1.29

4.38

3.8

3.9

—

Other neurotic disorders

150

2.22

4.38

3.5

4.7

—

Other diseases of arteries and capillaries

294

1.85

4.37

3.4

—

Other overlap syndromes

3.25

4.36

5.4

4.0

—

Abnormal findings in nipple discharge synovial fluid wound secretions

3.40

4.35

5.4

4.1

—

Superficial injury of wrist and hand

542

1.61

4.34

4.3

3.9

—

Disorders of vitreous body and globe

268

2004

1.31

4.34

4.1

3.6

—

Osteomyelitis

197

2.05

4.34

3.8

3.7

—

Mixed conductive and sensorineural hearing loss

443

1.68

4.33

3.5

3.3

—

Inflammatory diseases of the central nervous system

253

1.91

4.30

4.3

3.7

—

Unstable angina pectoris

238

1486

1.33

4.29

3.4

3.6

—

Disorders of muscles

296

1.83

4.28

3.6

3.7

—

Personal history of other diseases and conditions

231

1.95

4.28

3.3

4.1

—

Cerebral palsy and other paralytic syndromes

348

1.76

4.25

3.7

—

Alzheimer disease

1063

0.64

4.23

3.1

3.5

—

Ventral hernia

123

834

1.48

4.21

3.9

3.6

—

Hypokalaemia

364

1.74

4.20

3.5

4.0

—

Other and unspecified diseases of blood and blood-forming organs

2.70

4.18

2.5

4.1

—

Acute laryngitis and tracheitis

217

1.96

4.16

4.8

3.6

—

Monoamine oxidase A inhibitors

358

1.74

4.15

3.3

3.9

—

Other superficial mycoses

3.03

4.14

3.2

3.6

—

Emotionally unstable personality disorder

228

1.94

4.14

3.1

4.3

—

Selective deficiency of immunoglobulin A [IgA]y

8.36

4.11

4.5

3.0

—

Blepharochalasis

156

1112

1.41

4.10

3.5

3.6

—

Benign neoplasm: Stomach

279

1.84

4.09

3.5

3.9

—

Rare circulating lymphoid malignancy

2.53

4.06

4.0

—

Biomechanical lesions, not elsewhere classified

142

2.20

4.06

3.3

3.8

—

Impetigo

2.58

4.05

7.0

3.7

—

Extrapyramidal and movement disorders

199

1479

1.35

4.05

4.0

3.5

—

Any event in hilmo or specialist outpatient

+∞

4.04

2.6

0.0

—

Acute myeloid leukaemia and myelodysplastic syndromes

2.98

4.03

3.5

4.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

317

1.78

4.03

3.1

3.7

—

Mental disorders, not otherwise specified

189

2.02

4.03

3.6

4.1

—

Scoliosis

203

1.98

4.01

3.8

4.2

—

Post-traumatic wound infection, not elsewhere classified

2.70

4.01

5.7

4.3

—

Adhesive capsulitis of shoulder

562

1.57

4.00

3.4

3.7

—

Macular pucker

579

1.56

3.98

3.7

3.5

—

Phlebitis and thrombophlebitis (not including DVT)

112

755

1.49

3.97

3.8

3.6

—

Abrasion of teeth

116

574

1.49

3.96

4.0

3.7

—

Disorders of parathyroid gland

111

738

1.49

3.96

3.6

—

Valvular operations

470

1.62

3.96

3.6

3.8

—

Palmar fascial fibromatosis [Dupuytren]

612

1.54

3.94

3.5

3.6

—

Myocardial infarction, with ST-elevation

112

757

1.49

3.93

3.4

3.5

—

Hypersensitivity pneumonitis due to organic dust

2.94

3.93

4.7

4.1

—

Hallux valgus (acquired)

166

867

1.39

3.89

3.2

3.7

—

Other (seronegative) rheumatoid arthritis, wide

101

670

1.51

3.88

3.8

3.6

—

Suppurative and unspecified otitis media

137

852

1.43

3.88

4.8

4.2

—

Other/unspecified enthesopathies, not elsewhere classified

284

1.81

3.88

3.6

3.8

—

Inflammatory bowel disease

144

1023

1.41

3.88

3.5

3.8

—

Injury of unspecified body region

234

1.89

3.87

4.2

4.0

—

Metatarsalgia

241

1.88

3.87

3.5

4.1

—

Insulin, intermediate and long-acting

296

2292

1.27

3.86

3.3

3.7

—

Migraine with aura and triptan purchases

299

1.78

3.86

4.9

4.3

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

9.41

3.85

3.9

3.1

—

Keratitis

165

1202

1.38

3.84

4.4

3.7

—

Postmenopausal osteoporosis with pathological fracture

193

1.99

3.83

3.9

3.7

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

122

844

1.45

3.82

3.3

3.6

—

Gingival hyperplasia

2.62

3.82

3.5

5.2

—

Golimumab

2.62

3.81

4.5

3.9

—

Intestinal malabsorption

120

2.27

3.81

7.8

4.4

—

Degenerative diseases of the nervous system

108

1188

0.68

3.80

3.1

3.5

—

Schizophrenia or delusion, excluding more controls

123

846

1.45

3.79

3.4

4.1

—

Olecranon bursitis

208

1.94

3.77

3.7

4.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

152

1096

1.39

3.77

4.1

3.8

—

Hypertensive Renal Disease

108

2.34

3.77

3.0

3.2

—

Diabetic neuropathy

420

1.64

3.76

3.0

3.5

—

Systemic sclerosis (FG)

2.68

3.75

3.7

3.5

—

Assault by bodily force

167

2.05

3.75

4.6

3.9

—

Amiodarone users

408

1.65

3.74

3.3

3.6

—

Benign neoplasm of other and unspecified endocrine glands

362

1.69

3.74

3.3

4.0

—

Mucosal proctocolitis

355

1.70

3.72

3.4

3.8

—

Alcohol-induced acute pancreatitis

122

2.24

3.68

3.5

4.9

—

Other/unspecified enthesopathies of lower limb, excluding foot

175

2.01

3.68

3.9

4.2

—

Delirium, not induced by alcohol and other psychoactive substances

440

1.62

3.68

3.2

3.6

—

Urethral stricture

210

1.92

3.68

2.9

3.6

—

Insulin, fast-acting or short human

182

1356

1.34

3.67

3.8

3.7

—

Arthropathies in other diseases classified elsewhere

116

2.27

3.65

3.3

4.5

—

Carcinoma in situ of skin of ear and external auricular canal

3.32

3.65

3.1

3.5

—

Disorders of orbit

116

2.26

3.65

2.9

3.5

—

Dementia

150

1421

0.73

3.64

3.1

3.6

—

Fibrosis and cirrhosis of liver

254

1.82

3.63

4.1

3.8

—

Hypermobility syndrome

2.48

3.63

3.7

3.4

—

Misadventures to patients during surgical and medical care

450

1.61

3.63

3.6

3.7

—

Other congenital malformations

190

1.96

3.61

6.4

4.5

—

Viral agents as the cause of diseases classified to other chapters

2.78

3.60

4.9

4.0

—

Hernia of abdominal wall

236

1831

1.29

3.59

3.8

3.6

—

Cardiomyopathy, Hypertrophic obstructive

2.98

3.59

3.9

3.7

—

Hypersensitivity angiitis

5.51

3.56

4.2

3.6

—

Panic disorder

322

1.71

3.55

3.9

4.2

—

Umbilical hernia

132

941

1.41

3.53

3.5

3.6

—

Carcinoma in situ of skin of ear and external auricular canal

3.24

3.52

3.1

4.0

—

Mesothelioma, excluding all cancers (controls excluding all cancers)

3.24

3.52

2.1

3.9

—

Failure and rejection of transplanted organs and tissues

3.23

3.52

4.8

4.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

135

967

1.40

3.51

3.3

3.8

—

Other and unspecified nonorganic psychotic disorders

493

1.57

3.51

3.3

4.2

—

Excessive, frequent and irregular menstruation

155

623

1.39

3.49

4.2

4.0

—

Cysts of oral region, not elsewhere classified

112

2.25

3.48

4.1

4.6

—

Pedestrian injured in transport accident

200

1.91

3.48

4.5

3.6

—

Superficial injury of hip and thigh

494

1.56

3.48

3.0

3.7

—

Arthropathic psoriasis

355

1.67

3.47

3.3

3.8

—

Other benign neoplasms of skin

191

1448

1.32

3.47

4.0

3.6

—

Benign neoplasm of meninges

280

1.76

3.46

2.8

3.9

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

325

1.70

3.45

4.6

4.0

—

Alzheimer’s disease, wide definition

931

0.64

3.43

3.0

3.5

—

Other and/or unspecified nontoxic goitre

259

1.79

3.42

3.2

3.8

—

Other disorders of gingiva or/and edentulous alveolar ridge

126

2.16

3.42

3.3

4.3

—

Allergic contact dermatitis

349

1.67

3.41

3.7

3.8

—

Other renal tubulo-interstitial diseases

2.69

3.41

8.2

3.5

—

Systemic sclerosis

2.53

3.39

3.7

3.4

—

Diseases of middle ear and mastoid

241

1543

1.28

3.39

4.4

3.9

—

Diplopia

427

1.60

3.39

3.9

3.7

—

Polycystic ovarian syndrome, consortium definition

278

1327

1.27

3.38

4.2

3.8

—

Other and unspecified urticaria

546

1.52

3.37

3.8

4.1

—

Adult respiratory distress syndrome

3.30

3.36

2.8

4.2

—

Panniculitis, unspecified

3.51

3.36

2.7

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

2.75

3.34

7.6

4.7

—

Muscle strain

2.49

3.30

3.8

3.6

—

Extreme obesity with alveolar hypoventilation

115

2.19

3.29

3.9

3.6

—

Acute gastritis

255

1.78

3.29

3.4

3.7

—

Other/unspecified synovitis and tenosynovitis

345

1.66

3.29

3.6

3.8

—

Oxicams

133

539

1.41

3.29

3.4

4.1

—

Inflammatory diseases of female pelvic organs

232

1364

1.28

3.29

4.0

3.9

—

Secondary uncertain malignant neoplasm

478

1.56

3.28

2.9

3.6

—

Disorders of refraction and accommodation

106

734

1.44

3.28

4.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

284

2280

1.25

3.28

3.5

3.8

—

Dialysis

122

2.15

3.27

3.8

4.3

—

Benign neoplasm: Cerebral meninges

241

1.79

3.26

2.9

4.0

—

Other enthesopathy of foot (+metatarsalgia)

263

1.76

3.26

3.4

4.1

—

Chondropathies

447

1.57

3.26

3.6

3.9

—

Artrosis, including avohilmo

451

2067

1.20

3.25

3.5

3.8

—

Carcinoma in situ of skin of scalp and neck

2.42

3.25

4.5

3.0

—

Spondyloarthritis

575

1.50

3.25

3.6

—

Benign neoplasm of breast

316

1.68

3.24

4.0

3.5

—

Generalized anxiety disorder

316

1.68

3.24

3.8

4.6

—

Other diseases of jaws

170

1.95

3.24

2.6

4.0

—

Other and unspecified follicular disorders

103

2.25

3.23

3.6

3.7

—

Thoracic aortic aneurysm

520

1.53

3.23

3.4

3.5

—

Filling of root of tooth

2.46

3.22

4.2

3.7

—

Superficial injury of ankle and foot

294

1.71

3.22

4.4

4.2

—

Disorders of continuity of bone

257

1.76

3.21

5.0

4.2

—

!Aliquae complicationes praecoces traumatis

123

2.13

3.21

5.3

3.9

—

Early complications of trauma

123

2.13

3.21

5.3

3.9

—

Fracture of shoulder and upper arm

173

1309

1.32

3.20

3.9

3.8

—

Traumatic subarachnoid haemorrhage

110

2.20

3.20

2.9

4.4

—

Alcohol abuse, main dg

481

1.54

3.20

3.5

3.6

—

Diseases of the myoneural junction and muscle

434

1.57

3.19

2.9

3.7

—

Other peripheral vascular diseases

243

1.78

3.18

3.4

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

281

1.69

3.18

3.3

5.7

—

Diseases of spleen

2.67

3.15

2.5

3.7

—

Myeloid leukaemia

2.43

3.15

4.4

3.7

—

Cardiac arrest

147

1.94

3.13

3.6

4.1

—

Abnormal spermatozoa

498

0.50

3.13

3.0

3.6

—

Epilepsy

143

1054

1.36

3.12

3.4

3.8

—

Thyrotoxicosis

113

804

1.41

3.11

3.9

3.8

—

Haemorrhoids and perianal venous thrombosis

147

1092

1.35

3.09

3.2

3.6

—

Dementia, including avohilmo

169

1530

0.76

3.09

3.2

3.6

—

Acute alcohol intoxication, ICD10

631

1.46

3.09

3.3

3.7

—

L01XX Other antineoplastic agents

202

1.85

3.08

2.6

3.5

—

Chalazion

344

1.64

3.08

3.3

4.0

—

Neuroendocrine tumor and carcinoma of lung

3.55

3.08

3.3

3.8

—

Benign neoplasm: Descending colon

202

1.84

3.08

2.8

3.9

—

Systemic sclerosis, icd10

2.41

3.07

3.7

3.4

—

Symptoms and signs involving emotional state

2.45

3.05

7.2

4.0

—

Benign neoplasm: Adrenal gland

254

1.74

3.05

3.0

3.9

—

Persons encountering health services in other circumstances

155

1163

1.33

3.05

3.8

3.7

—

Cluster headache, strict

2.45

3.05

3.2

4.5

—

Other follicular disorders

181

1.89

3.05

3.5

4.5

—

Cholelithiasis, broad definition with cholecystitis

450

2601

1.19

3.05

3.4

3.7

—

Dermatitis due to substances taken internally

153

1.97

3.05

7.7

3.4

—

Benign neoplasm of breast

322

1.65

3.04

4.0

3.6

—

Melanocytic naevi of lower limb, including hip

106

2.19

3.03

6.1

3.7

—

Erectile dysfunction

323

1.65

3.02

3.2

3.5

—

Other disorders of conjunctiva

488

1.52

3.02

3.7

—

Other psoriatic arthropathies

323

1.65

3.01

3.2

3.9

—

Effects of foreign body entering through natural orifice

112

801

1.40

3.00

3.4

3.8

—

Achalasia of cardia

2.78

3.00

2.6

4.5

—

Diabetic nephropathy, excluding more controls

399

1.53

3.00

2.7

3.5

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

370

1.60

2.99

3.3

3.9

—

Otitis externa, unspecified

293

1.68

2.99

3.3

4.0

—

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

3.05

2.99

3.3

3.7

—

Myeloproliferative diseases

301

1.67

2.99

3.4

3.7

—

Nail disorders

241

1.75

2.97

5.2

3.6

—

Disorders of calcium metabolism

190

1.85

2.97

3.0

4.2

—

Chronic diseases of tonsils and adenoids

311

1606

1.23

2.96

3.6

3.8

—

Enthesopathies of lower limb, excluding foot

670

1.44

2.96

4.1

3.9

—

Event of undetermined intent

162

1.93

2.95

4.5

4.1

—

Panniculitis affecting regions of neck and back

2.29

2.94

3.7

—

Cervicobrachial syndrome

663

1.44

2.93

3.3

3.8

—

Eosinophilia

2.73

2.90

4.4

3.8

—

Hordeolum and other deep inflammation of eyelid

142

1.98

2.90

5.9

4.2

—

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

6.90

2.89

2.7

4.3

—

Essential (haemorrhagic) thrombocythaemia

115

2.11

2.89

4.4

3.4

—

Other and unspecified disorders of adult personality and behaviour

6.81

2.88

2.8

2.1

—

Obesity due to excess calories

190

1481

1.29

2.88

3.3

3.8

—

Idiopathic gout

359

1.60

2.87

3.3

3.7

—

Other interventions on the root canals of the tooth

2.96

2.87

3.5

3.6

—

Hypopituitarism

185

1.85

2.87

4.0

3.9

—

Anogenital herpesviral [herpes simplex] infection

122

2.06

2.87

5.0

4.2

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1090

0.70

2.87

3.4

3.9

—

Thyroiditis, ILD-related definition

297

1.66

2.86

3.9

4.0

—

Generalized skin eruption due to drugs and medicaments

109

2.13

2.85

8.9

3.6

—

Acute lymphadenitis

143

1.97

2.85

4.0

3.7

—

Acquired absence of organs, not elsewhere classified

2.82

2.84

2.9

3.5

—

Mesothelioma

2.82

2.84

2.1

4.0

—

Coronary revascularization (ANGIO or CABG)

259

1456

1.24

2.84

3.2

3.7

—

Other sleep disorders

321

1.63

2.83

3.3

3.8

—

Ulcerative colitis

108

777

1.39

2.82

3.5

3.8

—

Alzheimer’s disease (Late onset)

880

0.67

2.81

3.0

3.5

—

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

2.42

2.81

2.9

3.5

—

Diphtheria

8.98

2.80

2.6

3.2

—

Colonic or urogenital fistula

128

948

1.35

2.80

4.0

3.5

—

Osteopathy in diseases classified elsewhere

4.03

2.80

2.6

4.3

—

Atypical facial pain

144

1.96

2.80

3.7

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

4.02

2.80

6.9

4.2

—

Pyoderma gangrenosum

4.02

2.80

2.4

3.7

—

Postprocedural musculoskeletal disorders, not elsewhere classified

246

1.72

2.80

3.2

3.8

—

Thrombocytopenia, unspecified

231

1.74

2.80

3.6

3.8

—

Abdominal aortic aneurysm (AAA)

437

1.53

2.79

3.0

3.2

—

Myeloid leukaemia

2.29

2.78

4.4

4.0

—

Ovarian cyst

142

611

1.35

2.78

3.8

4.0

—

Tinnitus

111

805

1.38

2.78

4.3

3.5

—

Other obstructive and reflux uropathy

117

2.07

2.77

3.3

3.4

—

Psoriasis vulgaris

621

1.44

2.77

3.2

3.6

—

Iron deficiency anaemia secondary to blood loss (chronic)

547

1.47

2.77

3.4

3.5

—

Neuromuscular dysfunction of bladder

277

1.67

2.77

3.9

3.8

—

Scar conditions and fibrosis of skin

104

2.13

2.75

3.4

3.8

—

Superficial injury of abdomen, lower back and pelvis

451

1.51

2.73

3.4

4.0

—

Cirrhosis of liver, NAS

174

1.85

2.73

4.6

4.2

—

Charcot foot

2.75

2.73

2.7

3.7

—

Other and unspecified aplastic anaemias

3.03

2.71

3.3

4.0

—

Melanoma in situ

139

1.96

2.71

2.8

3.9

—

Other diseases of stomach and duodenum

211

1.76

2.71

3.8

4.0

—

Corneal ulcer

550

1.46

2.70

4.6

3.7

—

2.15

2.70

4.0

4.7

—

Carcinoma in situ of skin of scalp and neck

2.21

2.69

4.5

3.7

—

Amputation of foot

2.31

2.69

3.5

—

Psoriatic arthropathies, ICD10

334

1.59

2.68

3.2

3.9

—

Bitten or struck by other mammals

272

1.66

2.67

4.1

3.9

—

Benign lipomatous neoplasm

128

956

1.34

2.67

3.8

3.7

—

Attention to artificial openings

119

2.03

2.67

3.9

—

Other obstetric conditions, not elsewhere classified

285

1.53

2.67

3.4

4.3

—

Malignant neoplasm of heart, mediastinum and pleura

2.84

2.66

2.1

4.3

—

Oesophageal varices

140

1.95

2.66

6.9

4.1

—

Personal history of risk-factors, not elsewhere classified

3.17

2.66

3.6

3.9

—

Open wound of wrist and hand

190

1483

1.27

2.66

4.2

3.9

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

2.24

2.65

2.8

3.7

—

Multiple myeloma

2.24

2.65

2.8

3.7

—

Other and unspecified mood [affective] disorders

140

1.94

2.65

5.4

4.1

—

Disorders of tooth development and eruption

2.34

2.64

10.2

3.9

—

Open wound of ankle and foot

304

1.62

2.64

4.1

3.8

—

Maternal care for other conditions predominantly related to pregnancy

346

1.57

2.63

3.2

4.2

—

Melanocytic naevi of scalp and neck

2.57

2.62

2.9

3.6

—

Drug-induced Cushing's syndrome

7.92

2.62

2.6

3.4

—

Other and unspecified iridocyclitis

113

2.05

2.62

2.9

4.0

—

Benign neoplasm: Duodenum

2.28

2.62

4.3

3.3

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

2.27

2.61

4.4

3.4

—

Haemophagocytic lymphohistiocytosis

7.83

2.61

5.0

3.7

—

Somnolence, stupor and coma

120

2.01

2.61

5.6

3.8

—

Respiratory and cardiovascular disorders specific to the perinatal period

4.83

2.61

7.1

8.5

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

392

1.54

2.60

3.2

3.8

—

Gonarthrosis,primary

490

2654

1.16

2.60

3.3

3.7

—

Other disorders of glucose regulation and pancreatic internal secretion

259

1.67

2.60

3.4

3.9

—

Tongue abnormality

199

1.77

2.60

3.8

3.7

—

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

3.67

2.59

4.7

—

Acute myeloid leukaemia, helper endpoint

3.67

2.59

4.7

—

Hepatomegaly and splenomegaly, not elsewhere classified

3.67

2.59

4.9

3.6

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

188

1473

1.27

2.59

4.0

3.8

—

Drug-induced systemic lupus erythematosus

4.10

2.59

2.9

3.9

—

Malignant neoplasm of mesothelium and soft tissue

163

1.86

2.58

3.4

3.6

—

Disorder of mineral metabolism, other/unspecified

7.51

2.58

5.4

2.9

—

Congenital malformations of lung

7.48

2.58

4.0

3.4

—

Rheumatic fever incl heart disease

107

2.07

2.58

3.8

3.9

—

Cluster headache, wide

2.20

2.57

3.3

4.5

—

Otalgia

207

1.75

2.57

4.5

3.5

—

Other or unspecified common variable immunodeficiency

7.39

2.57

7.2

3.1

—

Use of rivastigmine

578

0.58

2.57

3.1

3.5

—

IgA nephropathy (IgA glomerulonephritis)

2.38

2.57

4.3

3.5

—

Other and unspecified glaucoma

268

1.65

2.56

3.6

3.9

—

Acute generalized exanthematous pustulosis

128

1.97

2.56

8.4

3.5

—

Other disorders of the genitourinary system

402

1.52

2.55

3.0

3.6

—

Viral and other specified intestinal infections

479

1.47

2.55

5.4

4.4

—

Drug-induced cataract

2.25

2.55

3.3

3.9

—

Migraine without aura

386

1.53

2.54

3.4

4.4

—

Other specified/unspecified hearing loss

292

1.62

2.54

3.7

3.3

—

Oral leukoplakia and related diseases

186

1.79

2.53

3.4

3.5

—

Diabetic retinopathy, strict definition

605

0.62

2.52

3.0

3.5

—

Toxic effects of substances chiefly nonmedicinal as to source

316

1.59

2.51

3.5

4.1

—

Benign neoplasm of ovary

501

1.46

2.51

3.4

3.5

—

Type 1 diabetes

106

776

1.37

2.51

3.5

4.0

—

Use of galantamine

272

0.40

2.51

3.4

—

Other and unspecified myopathies

309

1.59

2.49

2.9

3.9

—

Nonalcoholic fatty liver disease

270

1.64

2.49

3.1

4.1

—

Diseases of male genital organs

295

1231

1.21

2.49

4.2

3.8

—

Myeloproliferative diseases (CML excluded)

278

1.63

2.49

3.5

3.8

—

Dissocial personality disorder

2.85

2.48

3.5

3.9

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

302

1.59

2.46

3.9

4.1

—

Postzoster neuralgia

2.59

2.46

3.3

4.1

—

Benign neoplasm: Skin of eyelid, including canthus

479

1.47

2.46

3.6

3.7

—

Other keratitis

318

1.58

2.46

4.9

3.7

—

Premature rupture of membranes

290

0.51

2.45

2.6

4.4

—

Orthopaedic devices associated with adverse incidents

0.00

2.44

0.0

3.8

—

Ganglion

604

1.41

2.44

4.0

3.9

—

Benign neoplasm: Skin of other and unspecified parts of face

319

1.57

2.43

3.8

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

212

1332

1.24

2.42

3.7

—

Cholelithiasis

428

2578

1.17

2.42

3.4

3.7

—

Hyperkinetic disorders, excluding more controls

120

1.95

2.42

2.5

5.9

—

Chronic conjunctivitis

2.19

2.42

3.9

3.8

—

Bulimia nervosa (incl. atypical)

2.95

2.41

3.0

3.3

—

Other specified/unspecified soft tissue disorders

138

1.90

2.41

2.8

3.4

—

Melanocytic naevi of lower limb, including hip

117

1.98

2.41

6.1

3.8

—

Conductive and sensorineural hearing loss

425

2528

1.17

2.41

4.3

3.6

—

Immunodeficiency associated with other major defects

6.52

2.40

4.2

2.6

—

Carcinoma in situ of skin of lip

6.51

2.40

3.0

4.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

376

1.52

2.39

3.7

4.3

—

Meralgia paraesthetica

2.08

2.38

3.0

3.8

—

Thyrotoxicosis, other and/or unspecified

599

1.41

2.37

3.8

4.1

—

Special screening examination for other diseases and disorders

205

1.71

2.36

3.0

3.4

—

Spondylolisthesis/Spondylolysis

566

1.42

2.36

4.2

3.8

—

Behavioural disorders, excluding more controls

3.65

2.36

3.5

5.2

—

Fracture of forearm

244

1879

1.22

2.36

4.3

3.8

—

Injury of other and unspecified intrathoracic organs

213

1.70

2.36

2.6

3.9

—

Degeneration of macula and posterior pole

264

1802

1.21

2.36

3.5

3.6

—

L04AC Interleukin inhibitors

125

1.93

2.36

4.3

3.6

—

Nontoxic goitre/thyroid nodule

142

1099

1.30

2.35

3.2

3.7

—

Injury of muscle and tendon at shoulder and upper arm level

180

1435

1.26

2.35

3.5

3.6

—

Entropion and trichiasis of eyelid

330

1.55

2.35

3.5

—

Idiopathic thrombocytopenic purpura

2.11

2.33

4.1

4.0

—

Pedestrian injured in collision with pedal cycle

2.11

2.33

4.5

4.0

—

Hemiplegia

147

1.85

2.33

3.4

4.1

—

Coronary angioplasty

207

1284

1.24

2.32

3.3

3.6

—

Vitamin deficiency, wide

140

1.87

2.32

3.9

3.8

—

Vitamin deficiency

140

1.87

2.32

3.9

3.8

—

Other retinal disorders

337

2294

1.18

2.32

3.6

3.7

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

133

1.89

2.31

2.6

4.1

—

Torticollis

3.24

2.31

2.7

4.8

—

Polyarthritis, unspecified

105

2.01

2.31

3.2

3.8

—

Other mycoses, not elsewhere classified/unspecified

4.82

2.30

5.8

4.1

—

Malignant neoplasm of thymus

4.81

2.30

2.7

3.2

—

Hydronephrosis

388

1.50

2.30

3.7

3.3

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

207

1.70

2.29

3.3

4.3

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

722

1.36

2.29

3.8

3.6

—

Iridocyclitis

100

739

1.36

2.29

3.0

3.5

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

2.49

2.29

2.6

3.7

—

Assault by sharp object

2.71

2.28

4.6

3.8

—

Familial hypercholesterolemia

587

1.40

2.28

3.6

3.7

—

Paranoid personality disorder

2.58

2.28

5.0

4.4

—

Abnormal blood-pressure reading, without diagnosis

2.23

2.27

3.3

3.0

—

Short stature, not elsewhere classified

4.71

2.27

10.8

10.3

—

Alcoholic liver disease

365

1.51

2.27

2.8

3.7

—

Thrombotic microangiopathy

3.98

2.27

7.1

3.7

—

Lichen planus

422

1.47

2.26

3.5

3.8

—

Exposure to other and unspecified inanimate mechanical forces

193

1.72

2.26

4.4

4.3

—

Other benign neoplasms of connective and other soft tissue

262

1.61

2.26

3.7

4.1

—

Etanercept

156

1.80

2.25

4.0

3.7

—

Mixed disorders of conduct and emotions, excluding more controls

3.91

2.25

7.0

4.3

—

Carbimazole or st.post thyroidectomy, condition for graves disease

614

1.39

2.25

4.3

4.0

—

KRA_PSY_EATING, excluding more controls

2.06

2.25

3.2

5.2

—

Lichen simplex chronicus and prurigo

201

1.70

2.25

3.2

3.6

—

Failed induction of labour

0.00

2.24

0.0

4.7

—

Small plaque parapsoriasis

5.79

2.24

7.8

2.7

—

D07AA Corticosteroids, weak (group I)

398

1.48

2.24

4.1

4.3

—

Ulcer of oesophagus

263

1.61

2.23

3.4

3.5

—

Thalassaemia

5.72

2.23

4.2

3.0

—

Ascites

209

1.68

2.23

3.1

4.0

—

Meningitis, viral

5.69

2.23

2.6

3.4

—

Oesophageal obstruction

128

1.89

2.22

4.7

4.1

—

Postviral fatigue syndrome

5.63

2.22

3.8

3.1

—

Disorders of eyelid in diseases classified elsewhere

2.06

2.22

4.1

3.7

—

Cushing syndrome

2.82

2.21

2.4

4.1

—

Benign neoplasm: Other and unspecified parts of mouth

100

2.02

2.21

6.0

3.4

—

Cholecystitis

532

1.41

2.21

3.4

3.6

—

Toxic effect of ethanol

107

1.97

2.20

4.6

3.9

—

Monoplegia

2.53

2.20

4.0

3.6

—

Anti-inflammatory and antirheumatic products, non-steroids

151

590

1.29

2.19

3.4

4.7

—

Benign neoplasm: Stomach

336

1.53

2.19

3.5

3.7

—

Injuries to the neck

669

1.36

2.17

4.1

3.7

—

Chronic tubulo-interstitial nephritis

129

1.87

2.17

2.4

3.4

—

Superficial injury of shoulder and upper arm

345

1.51

2.16

3.7

3.8

—

Toxic effect of other and unspecified substances

3.04

2.15

3.2

4.2

—

Long labour

417

0.59

2.15

4.1

4.2

—

Other encephalitis

2.18

2.15

3.8

3.5

—

Open wound of abdomen, lower back and pelvis

2.18

2.15

2.9

4.1

—

Eating disorders

181

1.72

2.14

4.0

4.2

—

Spontaneous abortion

889

0.75

2.13

4.2

3.9

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

274

1.47

2.12

3.4

4.4

—

Fall involving bed

102

1.98

2.11

3.8

3.7

—

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

2.47

2.11

3.2

3.9

—

Uterine polyps

265

0.45

2.11

4.2

3.8

—

Other infective spondylopathies

5.26

2.10

2.6

4.2

—

Hallux rigidus

496

1.42

2.09

3.5

3.7

—

Other hearing loss

149

1160

1.27

2.09

3.3

3.5

—

Disseminated intravascular coagulation [defibrination syndrome]

5.18

2.09

2.6

3.9

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

5.15

2.09

2.8

3.2

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

5.15

2.09

3.2

3.3

—

Exophthalmic conditions

2.95

2.08

4.1

4.9

—

Benign neoplasm of meninges

324

1.52

2.08

2.8

3.9

—

Oral leukoplakia and related diseases, including avohilmo

300

1.54

2.08

3.3

3.9

—

Small cell lung cancer, helper endpoint

2.09

2.07

2.9

3.8

—

Small cell lung cancer

2.09

2.07

2.9

3.8

—

Conduct disorder

2.92

2.07

3.4

4.7

—

Encephalitis

2.09

2.07

5.4

3.5

—

Asymptomatic human immunodeficiency virus [HIV] infection status

3.58

2.07

4.1

3.9

—

Explicit fungal Sepsis

3.58

2.07

5.4

3.8

—

Nail dystrophy

3.58

2.07

2.6

4.1

—

Systemic disorders of connective tissue in diseases classified elsewhere

4.13

2.06

3.8

3.2

—

Benign neoplasm: Other and unspecified parts of mouth

103

1.96

2.06

6.0

3.7

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

4.11

2.06

4.5

3.5

—

Peritonsillar abscess

506

1.41

2.06

3.4

3.7

—

Plantar fascial fibromatosis

277

1.56

2.05

2.9

4.0

—

Dissociative [conversion] disorders

2.18

2.04

3.7

3.8

—

Complications of other internal prosthetic devices, implants and grafts

132

1.83

2.04

3.1

3.4

—

Cyst of kidney

246

1.59

2.04

3.9

3.7

—

Abnormal findings on examination of urine, without diagnosis

132

1.83

2.04

3.7

4.4

—

Unspecified dementia

445

0.61

2.03

2.5

3.4

—

Retinal detachments and breaks

183

1490

1.23

2.03

3.7

3.6

—

Abnormal involuntary movements

441

1.43

2.02

4.1

3.7

—

Melanoma in situ of trunk

2.54

2.02

2.5

4.2

—

Neuralgia and neuritis, unspecified

147

1.78

2.02

5.0

4.3

—

Melanocytic naevi of other and unspecified parts of face

147

1.78

2.02

3.3

—

Inflammatory disease of uterus

294

1.53

2.02

3.5

4.1

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

3.11

2.02

7.5

3.7

—

Morphin

2.53

2.02

6.8

3.5

—

Other diseases of spinal cord

2.06

2.02

3.6

4.3

—

Other and unspecified acquired haemolytic anaemias

2.86

2.01

2.9

3.7

—

Personal history of medical treatment

2.86

2.01

3.0

3.3

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

111

1.91

2.01

5.0

4.3

—

Acute posthaemorrhagic anaemia

111

1.91

2.01

3.9

3.6

—

Varicella [chickenpox]

111

1.90

2.01

2.9

3.8

—

Left bundle-branch block

216

1.63

2.00

3.3

3.7

—

Benign neoplasm of major salivary glands

287

1.54

2.00

3.8

4.1

—

Coronary artery bypass grafting

158

962

1.25

1.99

3.3

3.6

—

Unspecified nephritic syndrome

2.16

1.99

3.7

3.8

—

Juvenile osteochondrosis

2.16

1.98

3.7

3.9

—

Opening and dilatation of root channel of tooth

163

1.73

1.98

3.6

4.1

—

Tibial collateral bursitis [Pellegrini-Stieda]

3.37

1.97

2.9

4.0

—

Melanoma in situ

156

1.75

1.97

2.8

3.5

—

Varicose veins

320

2072

1.17

1.97

3.4

3.7

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

633

0.73

1.97

3.4

4.2

—

Disorders of the thyroid gland

469

2696

1.14

1.96

3.4

3.8

—

Restless leg syndrome

386

1.46

1.96

4.0

3.8

—

Hyperparathyroidism

631

1.35

1.96

3.5

3.6

—

Microscopic polyangiitis

3.05

1.96

7.3

3.2

—

Abnormal findings on diagnostic imaging of central nervous system

2.03

1.96

3.6

—

Male infertility

105

1.91

1.95

7.1

4.0

—

Fatigue fracture of vertebra

4.65

1.95

3.4

3.8

—

Other injuries of lower limb, level unspecified

3.02

1.95

3.3

3.1

—

Disorders of purine and pyrimidine metabolism

3.83

1.95

4.5

3.4

—

Other disorders starting during childhood or adolecense, excluding more controls

2.47

1.95

4.5

5.6

—

Mantle cell lymphoma

2.78

1.95

2.7

4.4

—

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

3.01

1.94

3.9

4.2

—

Previous suicide attempt

3.01

1.94

3.8

3.5

—

Melanoma in situ of trunk

2.48

1.94

2.5

4.1

—

Benign neoplasm: Appendix

2.77

1.94

3.6

3.7

—

Speech and linguistic disorders, excluding more controls

126

1.80

1.94

2.9

5.8

—

Childhood allergy (age < 16)

140

1.71

1.94

5.1

7.5

—

Galactorrhea

3.79

1.94

3.2

3.8

—

Other abnormal immunological findings in serum

2.47

1.93

5.3

3.3

—

Carcinoma in situ of skin, other sites/unspecified

2.60

1.93

4.2

3.4

—

Normal-pressure hydrocephalus

187

0.43

1.93

2.6

3.4

—

Benign neoplasm of other and unspecified endocrine glands

429

1.43

1.93

3.3

3.8

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

166

874

1.24

1.92

3.6

3.7

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

166

874

1.24

1.92

3.6

3.7

—

Sequelae of other and unspecified infectious and parasitic diseases

150

1.74

1.91

5.1

4.1

—

Dronedarone medication

1.97

1.91

3.6

4.5

—

Pregnancy hypertension

958

0.74

1.91

3.5

4.0

—

Pre-eclampsia

459

0.61

1.90

3.5

4.0

—

Recurrent dislocation and subluxation of joint

173

1.68

1.89

3.4

4.3

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

340

1.48

1.89

3.0

3.7

—

Disease of hard tissues of teeth, NOS

3.22

1.89

7.1

4.8

—

Conotruncal defects

3.21

1.88

5.7

3.2

—

Emotional disorders starting during childhood or adolecense, excluding more controls

2.68

1.88

4.2

4.4

—

Acute drug-induced interstitial lung disorder

2.92

1.88

2.8

4.4

—

Disorder of pancreatic internal secretion, other and/or unspecified

2.92

1.88

4.4

4.1

—

Artificial opening status

189

1.65

1.88

3.9

3.8

—

Rosacea

316

1.49

1.87

3.9

—

Dislocation, sprain and strain of joints and ligaments of knee

244

1912

1.19

1.87

3.7

4.0

—

Tubulo-interstitial nephritis, not specified as acute or chronic

228

1.59

1.87

3.0

3.2

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.11

1.87

3.3

3.6

—

Retinal vascular occlusion

474

1.40

1.87

3.3

3.5

—

Sequelae of cerebrovascular disease

183

1319

1.22

1.87

3.3

3.6

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

129

1.79

1.86

5.0

4.2

—

Anorexia (incl.atypical)

107

1.87

1.86

4.5

3.9

—

Perforation of oesophagus

3.62

1.85

3.8

4.9

—

Benign neoplasm of ovary

534

1.37

1.85

3.4

3.5

—

Lesion of ulnar nerve

458

1.40

1.85

4.6

3.8

—

Other acquired deformities of musculoskeletal system and connective tissue

152

1.72

1.83

2.9

3.6

—

Other congenital malformations of urinary system

4.25

1.83

1.8

3.5

—

Temporomandibular joint disorders

392

1.43

1.83

3.9

4.3

—

Dental caries 2

309

2090

1.16

1.82

4.4

3.9

—

Malignant neoplasm of bladder

302

1.50

1.82

4.3

3.4

—

Other abnormalities of plasma proteins

2.29

1.82

6.2

3.8

—

Oral lichen ruber planus

2.07

1.81

4.5

3.6

—

Erythema nodosum

1.93

1.80

3.2

3.5

—

Peroneal tendinitis

2.60

1.80

3.3

3.4

—

Benign neoplasm: Larynx

1.93

1.80

7.2

4.5

—

Certolizumab pegol

2.59

1.80

3.6

3.3

—

Other disorders of iris and ciliary body

2.02

1.80

2.5

4.1

—

Iron deficiency

2.59

1.80

5.9

3.6

—

Benign neoplasm of other and unspecified intrathoracic organs

2.80

1.80

2.7

3.7

—

Spondylopathies in diseases classified elsewhere

2.79

1.80

2.5

3.8

—

Salpingitis and oophoritis

503

1.38

1.79

4.0

3.7

—

Behavioural disorders

2.77

1.79

3.5

4.7

—

Any dementia

147

1278

0.81

1.77

3.0

3.5

—

Other noninfective disorders of lymphatic vessels and lymph nodes

102

1.88

1.76

3.2

3.7

—

Melanocytic naevi of scalp and neck

2.11

1.76

2.9

4.0

—

Artificial joint re-operation

256

1.53

1.76

3.1

3.9

—

Other disorders of pigmentation

139

1.74

1.76

4.3

3.3

—

Acute nasopharyngitis (common cold)

327

1.46

1.76

3.1

3.4

—

Injuries involving multiple body regions

1.91

1.75

7.7

3.6

—

Other forms of systemic lupus erythematosus

3.38

1.75

3.0

3.8

—

Other disorders of penis

313

1.48

1.75

4.5

3.5

—

Emergency coronary revascularization (for ACS)

307

1904

1.16

1.75

3.3

3.6

—

Spondylopathies (FG)

379

1.43

1.75

3.9

4.0

—

Acute myeloid leukaemia

2.54

1.75

4.7

4.1

—

Undefined dementia

435

0.63

1.75

2.5

3.5

—

Arterial embolism and thrombosis of lower extremity artery

117

1.81

1.74

2.6

3.3

—

Retinal vascular disorders

481

1.38

1.73

3.3

3.5

—

Unspecified parasitic disease

2.71

1.73

4.3

3.4

—

Collapsed vertebra, not elsewhere classified

2.97

1.73

3.9

4.3

—

Other acute viral hepatitis

2.70

1.73

2.3

4.4

—

Internal derangement of knee

166

1361

1.22

1.73

3.6

3.8

—

Moderate visual impairment, monocular

3.94

1.73

10.6

2.8

—

Toxic effect of organic solvents

3.94

1.73

3.0

2.8

—

Necrotizing fasciitis

3.93

1.73

6.8

2.2

—

Unspecified transport accident

3.93

1.72

3.6

3.0

—

Mixed disorders of conduct and emotions

2.93

1.72

7.0

6.3

—

Viral encephalitis, not elsewhere classified/unspecified

2.15

1.72

3.2

3.8

—

Disturbances of smell and taste

125

1.77

1.72

2.9

3.8

—

Osteonecrosis due to drugs

2.33

1.72

3.9

4.1

—

Benign neoplasm: Duodenum

1.89

1.71

4.3

3.7

—

Malignant neoplasm of larynx

2.32

1.71

8.9

3.9

—

conjunctival haemorrhage

266

1.51

1.71

4.1

3.9

—

Benign neoplasm: Descending colon

242

1.54

1.71

2.8

3.6

—

Other disorders of nervous system

218

1.57

1.70

3.1

3.8

—

Superficial injuries involving multiple body regions

2.07

1.70

6.0

3.9

—

Hodgkin lymphoma

2.07

1.70

3.4

3.7

—

Corneal scars and opacities

1.97

1.70

2.8

4.0

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

647

1.32

1.69

4.1

3.8

—

Drug-induced gout

3.24

1.68

4.3

4.9

—

Other disorders of breast

292

1.48

1.66

3.5

4.0

—

Vascular diseases of the intestine

134

1.73

1.66

3.1

3.4

—

Parodontitis, under 40 years

119

1.77

1.66

7.1

4.5

—

Other and unspecified nerve root and plexus disorders, also in other diseases

580

1.33

1.65

3.3

3.7

—

Dislocation, sprain and strain of joints and ligaments of thorax

1.94

1.65

2.8

3.7

—

Hypothyroidism, strict autoimmune

336

1942

1.15

1.64

3.3

3.7

—

Drug-induced myopathy

3.70

1.63

3.0

3.5

—

Other acute skin changes due to ultraviolet radiation

105

1.82

1.63

3.7

4.4

—

Traumatic subdural haemorrhage

470

1.36

1.63

2.9

3.5

—

Rheumatoid lung disease

3.67

1.63

4.8

3.9

—

Chronic nephritic syndrome

135

1.71

1.63

3.9

4.2

—

Alzheimer’s disease (Atypical or mixed)

352

0.59

1.62

3.6

3.4

—

Other degenerative diseases of the basal ganglia

2.17

1.62

2.7

4.2

—

Sequelae of injuries of upper limb

294

1.47

1.62

3.7

4.0

—

Premenstrual syndrome

3.60

1.62

2.8

3.1

—

3.59

1.61

8.8

3.4

—

Glaucoma suspect

121

1500

0.81

1.61

3.2

3.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

447

1.37

1.61

3.5

4.1

—

Menorrhagia

135

601

1.24

1.60

4.1

3.9

—

Benign neoplasm: Cerebral meninges

295

1.46

1.60

2.9

3.9

—

Syphilis

2.02

1.59

2.9

4.3

—

Other noninflammatory disorders of vulva and perineum

198

1.57

1.59

3.6

4.1

—

Other and unspecified disorders of pigmentation

2.74

1.59

3.6

3.5

—

Injury of blood vessels at wrist and hand level

3.05

1.59

4.8

3.4

—

Atrophic disorders of skin

404

1.39

1.59

4.2

3.5

—

Otitis media, unspecified

204

1.54

1.58

5.7

3.4

—

Schizophrenia or delusion

123

991

1.24

1.58

3.4

3.9

—

Parodontitis, under 40 years, or operation codes

121

1.74

1.58

7.1

4.5

—

Crohn's disease NAS

175

1.61

1.57

3.1

4.0

—

Excessive vomiting in pregnancy

144

1.67

1.57

2.8

4.2

—

Ankylosing spondylitis

247

1.50

1.57

4.1

3.8

—

Presence of other functional implants

303

1869

1.15

1.56

3.6

—

Dental caries 2 and operation codes

299

2069

1.15

1.56

4.4

3.9

—

DVT of lower extremities

682

1.29

1.56

3.6

—

Other specified/unspecified inflammatory spondylopathies

1.85

1.56

3.4

3.5

—

Emotional disorders and disorders of social functioning with onset specific to childhood

2.30

1.55

4.4

6.5

—

Viral conjunctivitis

2.12

1.55

2.9

3.8

—

Lichen planus, including avohilmo

630

1.30

1.55

3.6

3.7

—

Malignant neoplasm of other connective and soft tissue

1.94

1.55

4.5

4.2

—

Crushed, pushed or stepped on by crowd or human stampede

168

1.61

1.55

4.1

4.3

—

Paralytic ileus

122

1.73

1.55

2.8

4.3

—

Other noninflammatory disorders of vagina

168

1.61

1.55

3.5

4.2

—

Myelodysplastic syndrome

2.46

1.55

2.3

4.7

—

Combined immunodeficiencies

2.45

1.54

5.8

4.8

—

Carcinoma in situ of skin of lip

3.45

1.54

3.0

3.6

—

Congenital malformations of the urinary system

145

1.66

1.54

3.3

4.3

—

Polyarteritis nodosa and related conditions

2.30

1.54

6.1

3.5

—

Thyroiditis

192

1.57

1.54

4.5

3.4

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

3.43

1.54

5.0

3.5

—

Open wound of thorax

2.30

1.54

2.3

4.0

—

Implicit parasitic Sepsis

3.40

1.53

3.0

4.6

—

Benign neoplasm: Short bones of upper limb

0.00

1.52

0.0

3.1

—

Disorders in reading

3.35

1.52

3.2

4.0

—

Anterior Iridocyclitis

667

1.29

1.52

3.0

3.7

—

False labour

349

0.68

1.52

3.4

4.3

—

Intentional self-harm by unspecified means

2.62

1.52

4.6

4.1

—

Other and unspecified rosacea

241

1.50

1.52

2.9

3.8

—

Other/unspecified crystal arthropathies

2.91

1.51

2.2

4.2

—

Other and unspecified papulosquamous disorders

2.91

1.51

2.3

4.2

—

Cardiomyopathies, Secondary/extrinsic

2.91

1.51

3.5

3.2

—

Acne

169

1.60

1.51

4.6

5.0

—

Benign neoplasm: Anus and anal canal

1.87

1.51

2.5

3.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

434

1.36

1.50

3.3

3.9

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

157

792

1.21

1.50

3.1

3.8

—

Benign neoplasm: Rectosigmoid junction

131

1.69

1.50

4.1

—

Injury of muscle and tendon at forearm level

2.09

1.50

4.3

3.4

—

Injury of muscle and tendon at wrist and hand level

443

1.36

1.49

3.9

3.4

—

Pure hyperglyceridaemia

1.96

1.49

4.4

3.7

—

Amyloidosis

2.02

1.49

3.2

4.0

—

Benign neoplasm: Appendix

2.47

1.49

3.6

4.1

—

Migraine without aura and triptan purchases

308

1.43

1.49

3.5

4.2

—

Other papulosquamous disorders

2.46

1.49

3.0

3.5

—

Cluster headache, strict, including avohilmo

116

1.73

1.49

3.2

3.8

—

Benign neoplasm: Oesophagus

2.46

1.48

3.8

3.4

—

Haemangioma and lymphangioma, any site

226

1.51

1.48

3.0

3.9

—

Other disorders of optic [2nd] nerve and visual pathways

186

1.57

1.48

5.4

4.1

—

Acute epiglottitis

2.45

1.48

3.3

3.7

—

Noninflammatory disorders of female genital tract

151

624

1.22

1.48

3.5

4.0

—

Other shoulder lesions

259

1.47

1.48

3.7

4.0

—

Other bursopathies

419

1.36

1.47

3.4

3.7

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.85

1.46

3.8

3.7

—

Unspecified misadventure during surgical and medical care

171

1.59

1.46

2.7

4.2

—

Acute and subacute iridocyclitis

619

1.30

1.45

3.0

3.6

—

Rheumatic valve diseases

1.89

1.45

3.9

3.7

—

Total colectomy operation

117

1.72

1.45

3.1

3.9

—

Total colectomy

117

1.72

1.45

3.1

3.9

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

3.21

1.45

3.8

3.6

—

Other disorders of Eustachian tube

1.89

1.45

4.1

3.5

—

Benign neoplasm: Skin, unspecified

102

1.77

1.45

3.8

3.4

—

Benign neoplasm: Liver

2.13

1.45

2.7

4.3

—

Other and unspecified parapsoriasis

2.79

1.45

8.2

4.2

—

Prolapse and hernia of ovary and fallopian tube

116

1.72

1.44

3.9

3.6

—

Malignant neoplasm of corpus uteri

266

0.56

1.44

3.4

3.6

—

2.76

1.44

3.7

3.8

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

2.34

1.44

3.2

3.7

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

639

1.29

1.44

4.1

4.2

—

Melanoma in situ of other and unspecified parts of face

2.34

1.44

3.2

3.9

—

Artificial joint operation, meniscal resection

470

2815

1.11

1.44

3.2

3.8

—

IBD patients in KELA-register

682

1.28

1.43

3.6

3.9

—

Cluster headache, wide,, including avohilmo

125

1.69

1.43

3.2

3.8

—

Melanocytic naevi of other and unspecified parts of face

164

1.59

1.43

3.3

3.5

—

Procreative management

107

724

1.25

1.43

5.6

4.4

—

Medical abortion

242

1133

1.16

1.42

3.7

3.9

—

Postpartum haemorrhage

412

0.68

1.42

3.6

4.2

—

Other dialysis

1.83

1.42

4.6

3.7

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

102

817

1.25

1.41

3.2

3.9

—

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

2.28

1.41

3.2

3.8

—

Carcinoma in situ of skin, other sites/unspecified

2.20

1.41

4.2

4.4

—

Other ill-defined and unspecified causes of mortality

251

0.56

1.40

2.9

3.5

—

Benign neoplasm: Pancreas

1.87

1.40

2.5

3.4

—

Benign neoplasm: Spinal cord

2.27

1.40

5.6

4.6

—

Dermatopolymyositis (FG)

2.27

1.40

4.0

3.6

—

Sequelae of injuries of head

157

1.60

1.40

5.0

4.2

—

Protein-energy malnutrition of moderate and mild degree

2.45

1.40

2.7

4.4

—

Vasomotor rhinitis (mode)

197

1.53

1.40

3.7

3.2

—

Benign neoplasm: Connective and other soft tissue, unspecified

2.44

1.39

4.3

3.6

—

Scleritis

2.44

1.39

2.7

3.8

—

Female genital prolapse

119

556

1.24

1.39

3.6

3.8

—

Hydrocephalus

288

0.59

1.39

2.6

3.8

—

Open wound of hip and thigh

1.90

1.39

3.0

3.7

—

Benign neoplasm: Skin of eyelid, including canthus

536

1.31

1.39

3.6

—

Benign neoplasm: Liver

2.09

1.39

2.7

4.0

—

Ill-defined and unknown causes of mortality

275

0.58

1.38

3.1

3.4

—

Benign neoplasm: Liver/bile ducts

2.01

1.38

2.8

4.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.95

1.38

4.1

5.8

—

Disorders of optic nerve and visual pathways

255

1.46

1.38

4.9

3.9

—

Haemangioma, any site

214

1.50

1.38

3.0

3.9

—

Dental caries 1 and operation codes, only avohilmo

131

538

1.23

1.38

4.2

4.3

—

Benign neoplasm: Oesophagus

2.22

1.37

3.8

3.9

—

Adenomyosis (Endometriosis of uterus)

407

1.35

1.37

4.6

4.0

—

Glucosamine medication

263

1833

1.15

1.37

3.4

3.7

—

Embolic stroke with flimmer

1.81

1.37

2.8

3.5

—

Benign neoplasm: Nasopharynx

2.64

1.37

2.5

3.7

—

Erectile dysfunction, exclusion

3.01

1.37

2.4

3.4

—

Certain conditions originating in the perinatal period

105

1.69

1.37

7.5

4.7

—

Personal history of certain other diseases

2.62

1.37

1.8

3.7

—

Malignant neoplasm of pancreas

236

0.55

1.37

2.8

3.8

—

Herpesviral keratitis and keratoconjunctivitis

127

1.66

1.37

3.0

3.7

—

Unspecified contracted kidney

2.99

1.36

3.4

3.6

—

Schizophrenia, schizotypal and delusional disorders

122

1001

1.22

1.36

3.4

3.9

—

Outcome of delivery

161

1.46

1.36

3.1

4.3

—

Nontoxic single thyroid nodule

215

1.49

1.35

2.7

3.7

—

Temporomandibular joint disorders, including avohilmo

138

1146

1.20

1.35

3.6

4.0

—

Overjet

0.00

1.34

0.0

6.5

—

Orchitis and epididymitis

315

1.40

1.34

3.8

3.4

—

Foreign body in alimentary tract

159

1.58

1.34

3.3

4.1

—

Primary open-angle glaucoma

117

1386

0.82

1.34

3.5

3.6

—

Conductive hearing loss, unspecified

265

1.44

1.34

4.6

3.4

—

Benign lipomatous neoplasm of other sites/unspecified

265

1.44

1.34

2.8

4.0

—

Perioral dermatitis

2.16

1.34

8.6

3.4

—

Contraceptive management

100

871

0.81

1.33

4.6

4.0

—

Isolated proteinuria

1.79

1.33

4.1

3.9

—

Seronegative rheumatoid arthritis

358

1.37

1.33

4.1

3.8

—

Injury of muscle and tendon at ankle and foot level

2.05

1.33

3.0

3.7

—

Unspecified lump in breast

436

1.33

1.32

3.4

3.6

—

Other otitis externa (chronic)

192

1.52

1.32

4.6

3.9

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

325

1.39

1.31

4.2

4.3

—

Disorders of magnesium metabolism

2.54

1.31

2.2

4.1

—

Use of disulfiram, acamprosate or naltrexone

258

1.44

1.31

3.3

4.0

—

Malignant neoplasm of ovary

150

0.46

1.31

4.0

3.6

—

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

2.53

1.31

2.7

3.4

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

2.11

1.31

2.2

3.7

—

Shock, not elsewhere classified

2.53

1.31

2.8

3.7

—

Other abnormal findings of blood chemistry

121

1.66

1.31

4.1

3.6

—

Dermatopolymyositis

2.11

1.31

4.0

3.3

—

Duodenal ulcer

411

1.34

1.30

3.9

3.5

—

Atrial septal defect

1.77

1.30

2.6

3.7

—

Sensorineural hearing loss

391

2457

1.11

1.30

4.2

3.6

—

Toxoplasmosis

2.82

1.29

3.2

3.7

—

Polycythaemia vera

114

1.68

1.28

2.7

3.5

—

Malnutrition

1.95

1.28

2.7

4.3

—

Hyperkinetic disorders

151

1.57

1.28

2.5

5.2

—

Portal vein thrombosis

2.02

1.28

2.8

4.0

—

Benign neoplasm: Liver/bile ducts

1.95

1.28

2.8

4.2

—

Nontoxic multinodular goitre

703

1.25

1.28

3.3

3.7

—

Mature T/NK-cell lymphomas, hilmo

2.07

1.27

2.2

3.9

—

Other sexually transmitted chlamydial diseases

1.72

1.27

4.8

4.4

—

Disturbance of activity and attention

136

1.60

1.26

2.5

5.1

—

Other salmonella infections

107

1.69

1.26

3.1

3.4

—

Other diseases of biliary tract

311

1.39

1.26

3.8

3.9

—

Decubitus ulcer and pressure area

211

1.48

1.25

3.6

3.2

—

Inflammatory bowel disease, strict (require KELA)

696

1.25

3.6

3.9

—

Other and unspecified mononeuropathies, also in other diseases

1.75

1.25

4.3

3.8

—

Irregular menses

143

974

1.19

1.25

4.4

3.8

—

Fibrosis of liver

2.44

1.25

2.0

4.3

—

Inflammatory diseases of prostate (prostatitis)

484

1.31

1.25

3.2

3.4

—

Benign neoplasm of other and unspecified intrathoracic organs

2.25

1.25

2.8

4.2

—

Isolated proteinuria with specified morphological lesion

2.25

1.25

4.4

3.6

—

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

2.24

1.24

2.6

3.9

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

380

1.35

1.24

4.7

3.6

—

Unspecified mental disorder

160

1361

1.18

1.24

3.4

3.9

—

Benign neoplasm: Rectosigmoid junction

139

1.59

1.23

4.1

3.8

—

Atopic conjunctivitis

100

1.71

1.23

3.2

3.6

—

Contusion of toe(s) without damage to nail

2.01

1.23

5.3

3.8

—

Injury of intra-abdominal organs

1.92

1.23

4.9

3.8

—

Single spontaneous delivery

116

748

0.82

1.23

3.5

4.2

—

Wide developmental disorders, excluding more controls

2.38

1.22

13.7

4.7

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

212

1.47

1.22

4.2

4.0

—

Phobic anxiety disorders

245

1.43

1.22

3.9

4.8

—

Bipolar affective disorders

468

1.31

1.22

2.8

4.0

—

Vitamin D deficiency

2.06

1.22

4.4

4.3

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

152

769

1.19

1.22

3.2

3.8

—

Congenital malformations of cardiac septa

150

1.55

1.22

3.0

4.4

—

Hypertrophy of tongue papillae

2.18

1.22

3.0

3.5

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

530

1.29

1.22

3.7

3.9

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.64

1.21

2.4

2.5

—

Dependence on enabling machines and devices, not elsewhere classified

2.17

1.21

3.4

—

Nummular dermatitis

280

1.40

1.20

3.1

3.4

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

101

1.69

1.20

3.1

4.2

—

Postprocedural disorders of nervous system

148

1.56

1.20

2.6

3.8

—

Benign neoplasm: Larynx

109

1.66

1.19

7.2

4.4

—

Postmenopausal atrophic vaginitis

105

516

1.23

1.19

3.8

—

Deficiency of other B group vitamins

1.89

1.18

3.4

4.0

—

Speech and linguistic disorders

150

1.54

1.18

2.9

4.9

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

240

1845

0.88

1.17

4.1

4.0

—

Triptan medication for migraine, single purchase ok

240

1845

0.88

1.17

4.1

4.0

—

Acute and transient psychotic disorders

324

1.36

1.17

3.7

3.9

—

Benign neoplasm: Parotid gland

231

1.43

1.17

3.8

4.1

—

Acne vulgaris

133

1.58

1.17

4.9

5.1

—

Infective dermatitis

376

1.33

1.17

3.9

3.5

—

Hypoglycaemia, other or unspecified

198

1.47

1.16

3.2

3.7

—

Crohn disease

376

1.33

1.16

3.2

3.8

—

Crystalline deposits in vitreous body

0.00

1.16

0.0

4.4

—

Malignant neoplasm of floor of mouth

2.54

1.16

2.8

4.0

—

Acute peritonitis

215

1.45

1.16

3.3

3.7

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

561

1.27

1.16

3.4

3.8

—

Benign neoplasm: Endocrine pancreas

2.54

1.16

2.4

4.1

—

Alzheimer’s disease (undefined), excluding more controls

0.00

1.16

0.0

3.6

—

Other disorders of peripheral nervous system

2.53

1.15

3.4

2.9

—

Sexual dysfunction

2.07

1.15

2.5

3.3

—

Benign neoplasm: Pharynx, unspecified

2.53

1.15

2.4

4.8

—

Myotonic disorders

2.52

1.15

4.4

2.9

—

Other injuries of spine and trunk, level unspecified

2.52

1.15

2.8

3.6

—

Benign neoplasm: Short bones of upper limb

0.00

1.15

0.0

3.8

—

Other disorders starting during childhood or adolescence

1.92

1.14

4.5

5.6

—

All dysplastic lesions of the cervix uteri, vagina or vulva

576

1.26

1.14

3.8

3.9

—

Eating disorder

118

1.61

1.14

3.2

4.3

—

Carcinoma in situ of cervix uteri

154

0.52

1.13

3.4

4.0

—

Motorcycle rider injured in noncollision transport accidents

1.85

1.13

2.8

3.6

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.85

1.13

2.3

3.8

—

Serous carcinoma of ovary

111

0.45

1.13

3.4

3.7

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

122

990

1.19

1.13

3.7

3.6

—

Single delivery by forceps and vacuum extractor

159

0.61

1.13

3.2

5.4

—

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

2.36

1.13

2.1

3.9

—

Secondary thrombocytopenia

2.02

1.12

3.9

3.8

—

Disorders of breast

173

1385

1.16

1.12

3.4

4.0

—

Colectomy operation

635

1.25

1.12

3.9

3.6

—

Benign lipomatous neoplasm

128

1080

1.19

1.12

3.8

3.6

—

Superficial injury of neck

2.01

1.12

4.0

3.6

—

Dental caries 3 and operation codes, only avohilmo

145

616

1.18

1.12

4.4

4.2

—

Retinal breaks without detachment

546

1.27

1.12

3.3

3.6

—

Other specified and unspecified retinal disorders

119

1.61

1.12

2.5

3.7

—

Primary open-angle glaucoma, strict

1139

0.82

1.12

3.5

3.7

—

Calcific tendinitis of shoulder

159

1.51

1.12

2.8

4.4

—

Other specified disorders of external ear

127

1.58

1.11

4.8

4.2

—

Other abnormal uterine and vaginal bleeding

528

1.23

1.11

3.7

3.9

—

Other inflammation of vagina/vulva

1.97

1.11

7.8

3.6

—

Malignant neoplasm of head and neck

328

1.35

1.10

5.1

3.6

—

Alcoholic cardiomyopathy

2.42

1.10

3.8

4.1

—

Other benign neoplasms of connective and other soft tissue

311

1.35

1.10

3.7

3.8

—

Dystonia

168

1.49

1.09

5.9

3.5

—

Atlantoaxial subluxation

2.41

1.09

2.6

4.1

—

Polyarteritis nodosa

2.41

1.09

8.6

3.8

—

Hydrocele

477

1.28

1.09

3.1

3.5

—

Degeneration of nervous system due to alcohol

1.74

1.09

2.9

4.9

—

Degeneration of the brain due to alcohol

1.74

1.09

2.9

5.0

—

Unspecified threat to breathing

2.40

1.09

3.8

3.2

—

Prurigo nodularis

1.74

1.09

3.4

3.8

—

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

1.97

1.09

3.8

3.6

—

Chondrocostal junction syndrome [Tietze]

112

1.62

1.09

3.3

3.8

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

144

1.54

1.09

3.3

4.0

—

Varicose veins of other sites

231

0.60

1.08

4.6

4.1

—

Malignant neoplasm of oropharynx

1.88

1.08

5.8

3.5

—

Optic atrophy

1.88

1.08

2.7

4.0

—

Disorders of synovium and tendon in diseases classified elsewhere

1.88

1.07

2.8

3.6

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1.69

1.07

3.1

3.8

—

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

279

0.64

1.07

4.1

3.6

—

Hyphaema and other vascular disorders of iris and ciliary body

1.94

1.06

2.7

4.3

—

Parapsoriasis

1.94

1.06

6.1

4.2

—

LSIL lesion of the cervix uteri, vagina or vulva

287

1.36

1.06

4.2

4.0

—

Nontoxic diffuse goitre

105

1.63

1.06

2.5

3.8

—

Other spirochaetal diseases

106

885

1.20

1.06

3.6

—

Ulcerative ileocolitis

105

1.63

1.06

4.2

3.9

—

Other symptoms and signs involving general sensations and perceptions

113

1.60

1.06

2.7

3.7

—

Cramp and spasm

129

1.56

1.05

3.9

3.5

—

Use of levodopa decarbox-comt-inhibitor

123

0.48

1.05

2.7

3.5

—

Crystal arthropathies, rheuma endpoint

1.81

1.05

3.1

3.9

—

Other crystal arthropathies

1.81

1.05

3.1

5.1

—

Cerebral atherosclerosis

2.01

1.05

3.0

4.1

—

Complications of labour and delivery

171

1099

0.87

1.05

3.7

4.0

—

Volvulus

1.80

1.05

2.2

3.8

—

Pathological resorption of teeth

1.80

1.05

3.0

5.5

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

195

1.44

1.04

5.0

4.1

—

Melanoma in situ of other and unspecified parts of face

1.98

1.04

3.2

4.5

—

Infective bursitis

1.68

1.04

4.0

4.7

—

Lumbosacral root disorders, not elsewhere classified

1.98

1.04

2.7

3.5

—

Other and unspecified medical devices associated with adverse incidents

2.31

1.04

3.4

4.3

—

Other specified/unspecified diseases of inner ear

2.31

1.04

2.6

4.0

—

Benign neoplasm: Spinal cord

1.97

1.04

5.6

4.0

—

Malignant neoplasm of nasal cavity and sinuses

2.30

1.04

4.2

3.0

—

Autoimmune hepatitis

2.30

1.04

2.0

4.7

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

2.29

1.03

3.0

—

Cerebral aneurysm, nonruptured

263

1.37

1.03

4.1

3.8

—

Postprocedural disorders of digestive system, not elsewhere classified

1.64

1.03

4.6

3.7

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mycobacterium sp identified in Sputum by Organism specific culture

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS